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ABSTRACT OF THE THESIS 
VASCULAR REACTIVITY OF ISOLA TED RAT MESENTERIC ARTERIOLES IN 
THE PRESENCE AND ABSENCE OF OUABAIN 
by 
Rohit Chawla 
Florida International University, 2006 
Miami, Florida 
Professor Nikolaos M. Tsoukias, Major Professor 
The microvasculature plays a significant role in the regulation of blood pressure 
and regional blood supply. Cardiotonic steroids like the adrenal cortical hormone 
(ouabain) have been proposed to play a role in some forms of hypertension. The 
purpose of this study was to determine the effect of different agonists on arteriolar 
diameter in the presence and absence of ouabain. 
In Vitro studies on isolated intact rat mesenteric arterioles were performed by 
administering different concentrations of the vasoconstrictor norepinephrine (NE) and 
the vasorelaxant acetylcholine (Ach) in the presence and absence of ouabain. NE 
induced constriction was not significantly enhanced in the presence of ouabain. Ach 
completely reversed NE-induced constriction without ouabain, which was significantly 
impaired in ouabain presence (p<O.O 1). NOS inhibition reduced the Ach-mediated 
relaxation significantly in the absence of ouabain (p<O.O l) whereas it was not 
significantly affected in ouabain presence. K+ Channel blockade almost completely 
abolished Ach-induced relaxation in presence and absence of ouabain. 
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presence and absence of ouabain. Also, the effect of ouabain on Ach-mediated relaxation 
was studied by comparing the relaxation responses in the presence and absence of 
ouabain. Further blockade of individual relaxing pathways (Cyclooxygenas~ pathway, 
NO-mediated pathway as well as EDHF-mediated pathway) was done with and without 
ouabain to further elucidate the pathway through which ouabain exerts its effect. 
2.0 HYPERTENSION 
Hypertension is an endemic disease in Western countries and is defined as a state 
when diastolic blood pressure (BP)> 90mmHg and/or systolic (BP)> 140mmHg. This is a 
very important health issue as hypertension is a major risk factor for premature death and 
diability from heart attack, heart failure, stroke and many other afflictions. (92). Within 
United States, approximately 20% of the population is hypertensive whereas more than 
50% of individuals over the age of 60 are hypertensive. Different factors are responsible 
for hypertension in the body including reduced functioning of the kidneys causing an 
increase in extracellular fluid leading to increased BP (54), genetics, adrenal cortical 
hormone, ouabain and other cardiotonic steroids. Some forms of hypertension are 
associated with an increase in ouabain levels. During hypertension, the blood pressure is 
higher due to reduced vessel diameter compared to normal conditions. This can be due to 
enhanced constriction of vessels to vasoconstrictors or impaired relaxation to 
vasorelaxants present in the body. The vessel diameter is regulated by an elaborate 
network of signaling pathways between the endothelial cells (EC) and smooth muscle 
cells (SMC) which form the vascular wall. 
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2.1 OUABAIN ACTION MECHANISM: BLAUSTEIN'S HYPOTHESIS 
Cardiotonic steroids, including the adrenal cortical hormone ouabain, have been 
proposed to play a critical role in linking salt intake to hypertension. Almost half of the 
patients with essential hypertension have increased levels of ouabain (52, 86) and chronic 
high salt intake causes an elevation in the concentration of cardiotonic steroids in plasma 
(56, 57). Several animal models of salt sensitive hypertension have also elevated levels of 
cardiotonic steroids (55, 56). The mechanisms of ouabain-induced inhibition of 
relaxation remain controversial. In rat thoracic aorta, ouabain caused impairment of 
relaxation to sodium nitroprusside (NO donor). Removal of the endothelium had no 
effect on the inhibition of relaxation and suggested involvement of effector pathways in 
SMC rather than endothelium (116, 117). On the other hand, ouabain-induced 
impairment of EC-dependent relaxation, reported in human resistance arteries, was 
attributed to compromised synthesis or release of EDRF ( 137). 
Almost thirty years ago Blaustein ( 1 0) proposed that cardiotonic steroids affect vascular 
resistance through inhibition of the Na+/K+ ATPase. The Na+/K+ ATPase pump present in 
the SMC plasma membrane is responsible for the removal of 3 Na+ ions from the SMC. 
High levels of ouabain blocks this pump thereby leading to an accumulation of Na+ inside 
the cell. The Na+/Ca2+ exchanger (also present in SMC plasma membrane) is responsible 
for the removal of Ca2+ from the cell along with intrusion of Na+ ions inside the cell. 
Thus, the increase in intracellular Na+ due to high ouabain levels lead to reversal of the 
+ ~+ h t . . 1· C ~+ Th C ~+ l . . Na /Ca- exchanger (NCX) t ere Jy mcreasmg cytoso 1c a- . e .<C accumu at10n Is 
amplified by the Ca2+ buffering system of the SR. Blaustein's hypothesis is illustrated 
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below in Fig 5. The left part of the figure shows a normal SMC and the right part 
illustrates the effect of high ouabain levels on SMC Ca2 +. 
Figure 1: Blaustein's hypothesis for the effect of ouabain-induced Na+/K+ pump on Ca2+ 
homeostasis. (Blaustein et al, 1977) 
Until recently, this hypothesis has been examined only indirectly in different 
hypertensive models producing inconclusive results for the role of NCX activity in 
hypertension (3, 4, 89, 98, 99). Recently inhibitors of NCX have been developed and 
provide the tools for directly assessing this mechanism in SMC. SEA0400 is a specific 
inhibitor of NCX, developed by Matsuda and colleagues that preferentially blocks the 
reverse mode (i.e. Ca2+ entry mode) of NCX (90). Recent experimental data utilizing this 
new inhibitor as well as transgenic animal models support Blaustein's hypothesis and 
provide evidence for the importance of NCX activity in salt sensitive hypertension (68). 
2.2 SALT SENSITIVITY 
Salt sensitivity appears m a significant percentage of the population and 
represents a major public health problem. It is associated with endothelial dysfunction 
and increased cardiovascular risk. The mechanisms that contribute to such susceptibility 
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remain largely unresolved. The mechanisms by which salt intake elevates blood pressure 
have also not been elucidated. Neurohormonal effects (28), alterations to the 
transmembrane Na+/Ca2+ transport (84), activation of the renin-angiotensin system and 
inhibition of the L-arginine-NO system ( 115) have emerged as major components in the 
pathophysiology of salt sensitivity. The L-arginine-NO system appears to be 
downregulated in Salt Sensitive (SS) hypertension. Impaired endothelium-derived 
vasodilation has been reported in SS humans (94) and animals (59, 60). Increased NO 
production by administration of L-arginine in Dahl SS rats abrogates salt sensitivity (21, 
63) and chronic NO blockade induces SS hypertension in control rats (97). The 
mechanisms that link SS to a decreased NO activity have not been resolved completely. 
Recent studies suggest decreased expression of eNOS (59, 60, 115), increased NO 
scavenging by 0 2- and decoupling of eNOS by increased levels of peroxynitrite in SS 
hypertension. 
2.3 Ca2+ HOMEOSTASIS IN SALT SENSITIVE HYPERTENSION 
Ca2+ mobilization plays a central role in the regulation of vascular tone and blood 
flow. In the ECs the intracellular concentration of free Ca2+ regulates release of 
vasoactive substance, while in the SMCs Ca2+ is the major determinant of contractility. 
Alterations in the mechanisms of its regulatory control may contribute to the 
pathogenesis of hypertension. Prior investigations have suggested altered Ca2+ dynamics 
in salt sensitivity and a direct effect of salt intake on c}+ dynamics in some vessels. 
Depressed endothelial Ca2+ responses to acetylcholine in the aorta of aldosterone-salt 
hypertensive rats have been reported (83). Altered EC Ca2+ dynamics may be responsible 
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for impaired endothelium dependent relaxations observed in different vascular beds 
(137). Further investigations are required to examine if this phenomenon appears in 
different vessels and particularly in microcirculatory vessels. 
3.0 .MICROCIRCULATORY PHYSIOLOGY, CALCilJl\1, ENDOTHELIUM-
DERVIED RELAXING f'ACTORS 
3.1 MICROCIRCULATORY PHYSIOLOGY 
Microcirculation is the flow of blood through the smallest vessels of the body as 
arterioles, capillaries and venules. These microvessels with diameters < 300 11m arc 
termed as resistance vessels as they offer maximum resistance to blood flow thereby 
playing a significant role in blood flow regulation. Various in-vitro studies on 
microcirculatory physiology have been performed on intact vessels as well as cultured 
cells. Studies on intact vessels preserve the presence of gap junctions and ion channels as 
present in the body and arc free from neuronal and hormonal controL These studies also 
allow to study the coordination of responses between endothelial cells (EC) and smooth 
muscle cells (SMC). Thus, in-vitro studies on intact rat mesenteric arterioles provide a 
valuable tool to understand microcirculatory physiology. 
3.1.1 Myogenic tone and Vasomotion 
Blood vessels respond to intra-luminal pressure increase with constriction. This 
behavior, known as myogenic response, is independent of neural, hormonal and 
metabolic influences and is inherent to SMC (27, 69). The myogenic response involves 
an increase in smooth muscle cell (SMC) Ca2+ concentration and a corresponding 
decrease in vessel diameter. An increase in transmural vessel pressure from l 0-30 mmHg 
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results in an increase in vessel diameter in rat microvcssel. However upon further 
increase in pressure to the physiological range of 40-60 mm Hg. an initial increase in the 
vessel diameter is followed by constriction (27). All vessels less than 150 jlm develop 
and maintain basal tone (27). Although the resting diameter continuously increases with 
increase in transluminal pressure, the slope of the pressure vs. diameter curve decreases 
with increase in pressure and tends to plateau. (5, Ill) This mechanism allows the blood 
vessels to adapt to changes in blood pressure and avoid indefinite expansion with 
pressure. ( l 11) 
Microvessels may also show rapid oscillations in diameter upon stimulation with 
agonists like potassium chloride (KCl) and norepinephrine (NE) ( 121 ). This phenomenon 
of repeated diameter oscillations in microvessels is termed as vasomotion. Vasomotion is 
not linked to physiological rhythms like heartbeat or breathing but is considered as an 
intrinsic cellular phenomenon caused due to a rapid increase and decrease in SMC Ca2+ 
concentrations (51, 53, 79). Vasomotion is suggested as a defense mechanism to 
counteract local hypoxic conditions as well as assist in efficient repartition of blood flow 
( !03). Previous reports have suggested the presence of a small SMC Ca2+ threshold for 
the onset of vasomotion and its abolishment at high agonist concentrations ( 121 ). Various 
studies have suggested the importance of careful handling of the vessels to reproduce 
vasomotion in-vitro, as it depends on the proper functioning of gap junctions and ion 
channels which can he easily disrupted due to over-stretching of the vesseL 
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3.2 CALCIUM 
Ca2+ is one of the most important physiological regulators which performs many 
functions at both micro and macro levels. (9) At the macro- scale Ca2+ is the structural 
component of hones and teeth. However, at the micro-scale, it assists in various 
physiological processes like maintenance of vascular tone, intra/intercellular signaling, 
gene expression, fertilization, learning and memory, metabolism, contraction, relaxation, 
vesicle trafficking and apoptosis (9). 
In the SMC, intracellular Ca2+ plays an important part in regulation of SMC 
contraction and relaxation (27). In general, increase in SMC Ca2+ concentration results in 
contraction whereas a decrease in Ca2+ concentration causes vasorelaxation. SMC 
contraction and relaxation regulates the microvessel diameter, which in turn, regulates 
blood flow rate. 
3.2.1 Calcium regulation in SMC 
Ca2+ concentration in the SMC can be increased by influx of extracellular Ca2+ through 
Ca2+ channels present in the plasma membrane or by opening of intracellular Ca2+ stores 
like the sarcoplasmic reticulum (SR). Influx of Ca2+ through Ca2+ channels can also 
influence the opening of intracellular Ca2+ stores leading to a fm1her increase in SMC 
Ca2+; a phenomenon termed as Ca2+ induced Ca2+ release (CICR) (50, 71 ). Potassium 
channels can hyperpolarize SMC leading to closure of voltage gated calcium channels, 
thereby reducing Ca2+ concentration in the SMC. Various channels, pumps and 
exchangers present in the rat mesenteric arteriolar SMC are shown in Fig.2: 
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Figure.2: Various ion channels, pumps and exchangers in a smooth muscle cell of rat 
mesenteric arteriole. 
The surface membrane of almost every animal cell expresses hundreds or even 
millions of copies of N;//K+ ATPases. This sodium pump rejects sodium towards the 
extracellular space and accumulates potassium in the intracellular medium thereby 
maintaining the sodium and potassium ionic gradients at the expense of ATP produced by 
the cell. These ionic gradients drive many co- and counter transporters allowing intake of 
glucose and amino acids, regulation of cell volume, pH and calcium homeostasis and are 
responsible for the electrical activity of all excitable cells. Na+/K+ ATPascs arc 
electrogenic as three sodium ions are extruded out of the cell while two potassium ions 
are transported. The activity of the pump contributes to the regulation of cell membrane 
potential. ( 45) 
Na+/K+ ATPase pump is composed of a noncovalently linked a subunit and a 
glycosilated B subunit Four isoforms of a subunit (a 1 to a4) and three isoforms of the p 
subunit CP 1 to f3 3) are found in mammalian cells. In mammalian arteries both vascular 
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SMC and EC express a 1 isoform of Na+/K+ ATPase. This isoform is almost completely 
activated at the physiological concentration of extracellular potassium (5mM) and in the 
rat is poorly sensitive to ouabain (ICso> 10(1)). However depending on the species, both 
SMC and EC can have a 2 and/or a 3 isoforms which are activated by potassium in the 
concentration range 3-lSmM and are more sensitive to inhibitory action of ouabain. The 
rat mesenteric arteriolar SMC contains only a l, a2 and a3 isoforms. (72, 135) 
Na+/Ca2+ exchanger 
SMC plasma membrane contains Na+/Ca2+ exchangers (NCX), which are 
involved in regulation of intracellular Ca2+. NCX is reported to have three major roles. 
Firstly, it plays a dominant role in the net removal of Ca2+ when cytoplasmic Ca2+ 
([Ca2+]cyt) level is high leading to cell activation. Although, Ca2+ entry via Ca2+ selective 
channels is much more dominant, NCX also mediates the entry of some Ca2+ during cell 
activation and depolarization. It also modulates the resting [Ca2+Lyt' even though more 
than one half of the Ca2+ removal under resting conditions may be mediated by low 
capacity high affinity ATP driven Ca2+ pump. (80, 136) 
Na+;e;}+ exchanger is a bi-directional electrogenic ion transporter protein which 
couples the translocation of 3 Na + in one direction to the translocation of 1 Ca2+ in the 
other (12). The Na+/Ca2+ exchanger uses energy of the Na+ electrochemical gradient to 
extrude intracellular Ca2+ (12). The extracellular Na + concentration is higher than the 
intracellular Na+ concentration and hence provides a gradient for Na+ movement. Na+/K+ 
A TPase pump blockade causes an mcrease in intracellular N a+ concentration which 
reverses the operating direction of NCX thereby resulting in translocation of Na+ outside 
the cell and Ca2+ into the ceil leading to intraceLlular Ca2+ increase. 
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Potassium Channels in the Vascular SMC \Vall 
Ion Channels are membrane protein complexes that allow selected ionic species to 
diffuse through lipid cell membrane. Potassium channels, which selectively pass 
potassium ions, are the largest and the most diverse type of ion channels. They play a 
critical role in regulating cell membrane potential, smooth muscle calcium and hence 
smooth muscle relaxation. K+ Channels are classified into four subgroups which are 
discussed below 
Voltage gated potassium channels (Kv channels) 
In SMC, the voltage activated potassium current is an important component of the 
outward potassium conductance and can be divided into two different types based on its 
inactivation properties: the delayed rectifier current (KDR) and the rapidly inactivating 
transient outward current (KTO). Depending on the species and the tissue studied, the 
vascular SMC can have both or either of Kv channels. However in EC, Kv channels arc 
rarely expressed. The activity of this channel plays a predominant role in the control of 
the cell membrane potential and thus the tone of vascular smooth muscle. Depolarization 
of the cell membrane, which can be caused by physical (intraluminar pressure-induced 
myogemc tone) or neurohormonal mediators (e.g. norepinephrine, cndothclin, 
angcotensin II) leads to the activation of these channels which serves as a useful 
protective mechanism 111 restoring membrane potential and preventing excessive 
contraction of the smooth muscle and thus vasospasm. This protective mechanism is 
referred to as the voltage-dependent brake. (65) 
Calcium activated potassium channels 
This family of calcium channels 1s divided into two subfamilies, small and 
intermediate conductance calcium activated potassium channels (a!so known as SKca and 
IKca respectively) and the large conductance calcium activated channels (also known as 
BKca). Only BKca channels are present on SMC plasma membrane whereas SKca and 
IKca are present on EC plasma membrane in rat mesenteric arterioles. 
Large conductance calcium activated potassium channels (BKca) 
BKca channels arc both voltage and calcium regulated potassium channels 
indicating that they play an important role in limiting the entry of calcium and the cell 
excitability. Its activity is increased when depolarizing voltages are applied and when the 
intracellular calcium concentration is increased. The calcium sensitivity of BKca lies in 
the region of negatively charged aspirate residues situated in the intracellular C-terminal 
called the "Ca2+ bowl''. BKca has been found to be present in the vascular smooth muscle 
and not in the endothelium in rat mesenteric artery. (62) 
Voltage operated Ca2+ channels 
Vascular smooth muscle cells have voltage gated Ca2+ channels (VGCC) which 
are further classified as L-type Ca2+ channels and T-type Ca2+ channels. VGCC plays an 
important role in influx of extracellular Ca2+ into the SMC (9, 70). SMC in the rat 
mesentery resistance arteries are reported to possess mostly L-type VGCC. 
Depolarization of SMC by 20-35 mY increases the opening probability of VGCC by 10-
15 times. (9) Vasoactive agents like KCI cause an increase in SMC Ca2+ by opening 
VGCC thereby causing inilux of Ca2+ from the extracellular medium into the SMC ( 121 ). 
Direct modulation of VGCC can also result from stretching of the vessel (9). 
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Receptor operated Ca2+ channels 
Ion channels present in SMC plasma membrane that open in response to binding 
of an extracellular ligand are termed as receptor operated channels. These channels 
contribute to the intlux of extracellular Ca2+ into the cell (9). The cell surface receptors 
include G-protein linked receptors and receptor tyrosine kinase (RTK). The major 
external stimuli that activate these channels are transmitters like A TP, acetylcholine, NE 
and glutamate (9). Upon stimulation, the signals generated include IP3, which is 
generated by hydrolysis of phosphatidylinositol-4,5-biphosphate (PIP2) by phospholipase 
C enzymes (PLCB and PLCy), cyclic ADP ribose (cADPR) and nicotinic acid 
dinucleotide phosphate (NAADP) (9). The signals generated also promote the release of 
Ca2+ from the intracellular stores. 
Plasma membrane Ca2+-ATPase (PMCA) 
Ca2+ adenosine triphosphatase or PMCA pumps are present on the SMC plasma 
membrane and play the most important role in the removal of intracellular Ca2+ (9, 70). 
However, the PMCA is responsible for sustained release of c}+ from the cell unlike the 
Na+/ Ca2+ exchangers, which are responsible for acute removal of intracellular Ca2+. 
PMCA is constituted from two distinct domains, an A TP binding cytoplasmic domain 
and a Ca2+ binding transmembrane domain. Phosphorylation of Asparate residue 
(Asp351) by terminal phosphate of ATP causes a con formational change of both the 
PMCA domains which, in turn, is responsible for transport of ci+ across the membrane. 
Release of Ca2+ acts as a signaling mechanism for hydrolysing Asp35l-Phosphate group 
and also returns the pump to its original state. Four different isoforms of PMCA exist 
(PMCA l, PMCA 2, PMCA 3, PMCA 4) of which PMCA l is the most abundant and 
l3 
present in rat mesenteric SMC. (70) PMCA pumps use the energy derived from the 
hydrolysis of A TP to Adenosine diphosphate (ADP) to remove Ca2+ from the cytoplasm 
thereby causing SMC relaxation in rat mesenteric arterioles. 
Store operated Ca2+ channels 
Depletion of intracellular stores like SR in the SMC results in opening of store 
operated Ca2+ channels (SOC) present in SMC plasma membrane. Agonists like 
norepinephrine stimulate SMC thereby causing an increase in SMC intracellular Ca2+ by 
releasing Ca2+ from SR through IP1 pathway (Fig J ). This increase in Ca2+ leads to SMC 
contraction. As Ca2+ is removed from the cell, the refilling of SR is explained by the 
presence of SOC as it allows the influx of Ca2+ from the extracellular space upon 
depletion of SR. 
Ca2+ channels present in SMC intracellular stores 
Release through ryanodine receptors (RyR) 
SR is the main intracellular Ca2+store present in the arterial SMC (9) and its 
membrane contains the ryanodinc receptors (RyR) family. The major activator of RyR is 
Ca2+ and it can act both from the lumenal and cytoplasmic side of the RyR channel. RyR 
activation ts regulated by cADPR, which IS generated by nicotinamide-
adcninedinucleotide (NAD) (9). An increase in Ca2+ present inside SR results in increased 
sensitivity of RyR on the SR surface. cADPR also mcreases the sensitivity of RyR on the 
SR surface (71 ). 
Increase in cytoplasmic Ca2+ which can result from activation of VGCC or by a 
receptor mediated mechanism causes activation of RyR thereby releasing Ca2+ from the 
SR In SMC, this calcium induced calcium release (CICR) primarily has an amplifying 
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effect on the increase in cytoplasmic Ca2+concentration (71 ). The Ca2+ release from the 
SR through RyR receptors can result in transient increases in cytoplasmic Ca2+ levels 
termed as Ca2+ sparks (71 ). Ca2+ release from the SR by RyR channels can also directly 
activate the Ca2+ activated potassium channels (Kca channels) This causes SMC 
hyperpolarization leading to inhibition of VGCC thus inhibiting contraction (27). 
Release through IP3 receptors 
In addition to RyR, SR also contains IP3 receptors (IP3R). Previous studies have 
reported the existence of two types of SR in the SMC; one contains only RyR and other 
both RyR and IP_~R (9). IP3 is generated by hydrolysis of membrane-associated 
phosphatidylinositol-4, 5-biphosphate (PIP2) by phospholipase C enzymes (PLq) and 
PLCy). Vasoactive agents like NE act by stimulation of PLC through membrane 
associated G protein. The reaction converts PIP2 to DAG and IP3 (9) (Fig l ). Ca2+ is the 
main regulator of the IP3R as an increase in luminal SR Ca2+ increases the IP_~R 
sensitivity thereby opening the IP3R Ca2+ channels. Previous reports on dependence of 
cytoplasmic c}+ levels on the TV,R sensitivity have been conflicting. Low Ca2+ 
concentration (1 00-300nM) in the cytoplasm is stimulatory for the IP,R but above 300nM 
Ca2+ becomes inhibitory and results in closure of IP3R gated Ca2+ channels (9). The 
relationship of Ca2+ levels and IP3R activation has been reported to be sigmoidal (9). The 
Ca2+ release from the SR as a result of IP3R activation has an amplifying effect on the 
cytosolic Ca2+ concentration which causes SMC contraction. DAG along with Ca2+ 
released from the intracellular stores activates protein kinase C. The activation of protein 
kinase C allows persistence of c}+ dependent re'iponses. Rapid hydrolysis of IP3 and 
deactivation of IP3R results in termination of Ca2"'" release from the SR. 
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SERCApumps 
Sarcoplasmic reticulum Ca2+ ATPase pumps (SERCA pumps), which are present 
on the SR membrane, sequester Ca2+ intracellular stores like SR and hence contribute to 
decrease cytoplasmic Ca2+ (9, 31 ). After Ca2+ is released from SR, SERCA pumps 
facilitate refilling of the SR as well as regulate intracellular Ca2+ levels. Similar to 
PMCA, SERCA pumps also use the energy derived from the hydrolysis of A TP to ADP 
to transfer Ca2+ from the cytoplasm in to the intracellular stores. 
Ca2+ buffering 
Ca2+ buffering m the SMC also plays a role in intracellular Ca2+ regulation. 
Intracellular Ca2+ exists as a complex with different proteins like calmodulin and troponin 
and is reversibly converted to free Ca2+. Most of the cytosolic Ca2+ (> 90%) exist as a 
complex with intracellular proteins. The amplitude and duration of the Ca2+ signal as well 
as spatial spreading of local Ca2+ signal depend on these cytosolic buffers. (9) 
3.2.2 Calcium regulation in ECs 
Endothelial cells (ECs) are located at the interface between blood and vessel wall 
smooth muscle cells (SMCs), playing an essential multifunctional role in both normal 
body homeostasis and various pathological conditions (1, 130). ECs are responsible for 
immunological response regulation, blood coagulation state, blood-tissue permeability, 
vessel repair, angiogenesis, and vascular tone modulation ( 130). They often respond to 
mechanochemical stimuli by either releasing different physiological signals or altering 
surface molecule expression and adhesion, gene expression, cytoskelctal remodeling, cell 
growth and angiogenesis ( 102). Endothelial control of vascular tone occurs by regulating 
the contractility of the surrounding blood vessel SMCs, therefore modulating blood tlow 
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and arterial pressure by altering the caliber of arteries and arterioles, most notably in 
microvessels (68, 102). 
In ECs, [Ci+Ji elevations lead to production of vasoactive substances, for 
instance prostanoids and NO, the latter being generated by Ca2+ -dependent activation of 
endothelial NO synthases (I 02). The initial rise in [Ca2+]i due to agonist stimulation 
commonly takes place via intracellular store Ca2 ~ release and the subsequent plateau is 
suppor1ed by extracellular Ca2+ entry ( 1, l 02 ). Calcium store depletion and the 
electrochemical driving force regulate Ca2+ influx from the extracellular medium. Fig.3 
illustrates the various channels, pumps and exchangers present in the EC which play a 
role in regulation of vascular tone and calcium homeostasis. In this study, the potassium 
channels present in the EC arc important as they form the basis for the action of EDHF 
pathway. Among the calcium activated potassium channels, only S Kca and IKca 
potassium channels arc present in EC of rat mesenteric arteries whereas only BKca 
channels are present in the SMC. Also, the SOC, NSCC, Na+/K+ ATPase pump and NCX 
are common to both SMC and EC plasma membrane and have been explained earlier. 
Figure 3: Various ion channels, pumps and exchangers present in EC of rat mesenteric 
artery 
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Channels which are present only on the EC plasma membrane are explained below: 
Small and Intermediate conductance calcium -activated potassium channels 
The SKca arc sensitive to an increase in intracellular calcium concentration (0.6-
O.htM) and are virtually voltage independent. They have small conductance to calcium 
compared to the IKca and BKca· The calcium sensitivity of the SKca channel is attributed 
to the association of the calcium binding protein calmodulin with the a subunit ( 138). 
This channel is blocked by toxins like apamin but is unaffected by charybdotoxin. The 
IKca has conductance intermediate between SKca and BKca and is insensitive to apamin 
or iberiotoxin but is blocked by charybdotoxin, Tram-34 and Tram-39. Rat mesenteric 
arteriolar endothelium is found to have SKca and IKca only. (16. 17, 23, 32, 34, 37, 46, 
62, 64, 77, 78, 105, 106, 125, 129) 
Inward rectifier potassium channels (KmJ 
These channels contribute to the hyperpolarization of the vascular smooth muscle 
leading to relaxation. These channels are sensitive to the extracellular potassium in the 
concentration range of 1 to 20mM and increase potassium entry into the cell causing the 
smooth muscle to hyperpolarize. These channels are present in almost all endothelial 
cells and contribute significantly to membrane potentials. Enothelial K!R channels arc 
activated not only by potassium but also by shear stress. In SMC, the expression of Km 
increases as the diameter of the artery decreases. ( l 04) 
3.2.3 Integration and Coordination of responses in the vascular wall: Gap 
junctional communication 
Integration and coordination of responses among the various cells composing a 
tissue is essential for the proper function of any given organ, including the blood vessel 
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wall. Cells can communicate by the release of various hormones, mediators etc as well as 
by direct electrical and chemical intercellular communications by means of gap junction 
channels. The coupling between smooth muscle cells. endothelial cells and 
endothelial/smooth muscle allows the transfer of signal between the various cells. 
Longitudinal cell-cell communication 
The communication signal can be in the form of ions diffusing across SMC 
through homocellular gap junctions. It can also be movement of Ca2+ and IP3 through the 
gap junctions and hence directly affect the contraction of far laying SMC in response to a 
highly localized application of a vasoconstrictor ( 41, 122-124 ). Studies conducted by 
Peng et al. ( 11 0) concluded that intracellular communication between SMC as seen in 
longitudinal signaling over long distances (several millimeters) along the vessel length is 
too fast to be explained by diffusion of chemical species like Ca2+ or IP3. There is 
evidence for longitudinal signaling to be electrical in nature ( 11 0). The synchronous 
contractions seen in SMC during a longitudinal response support the presence of an 
electrical signal traveling along the vessel length which is believed to travel on the cell 
plasma membrane. The electrical signal can result in membrane depolarization ( 1 1 0). 
Membrane depolarization can result in opening of VGCC (both L-Type and T-Type), 
which would cause an influx of extra cellular Ca2+. A synchronous increase of Ca2+ along 
the vessel length would result in synchronous contraction'> as seen during a vasomotor 
response (11 0). 
Radial cell-cell communication 
In cultured cells, heterocellular diffusion of Ca2+ and IP, has been determined to 
be slow, ( l ) however the geometry of arterioles allows a rapid diffusion of molecules 
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across a concentration gradient between the SMC and EC ( 123 ). Arterioles comprise of a 
layer of smooth muscle cells around a monolayer of endothelial cells. There is evidence 
for existence of connexin based heterocellular gap junctions between the two cell types 
(8 I). The EC volume has been determined to be less than lO of the SMC volume (33). 
This unique geometry allows a single endothelial cell to be in contact with a maximum of 
20 SMC. The diffusion time for Ca2+ from a SMC to an EC is believed to be less than 
lOO ms (41). This diffusion time is based upon a 2-micron diffusion distance and an 
estimate of Ca2+ diffusion coefficient in cytosolic extracts. The small diffusion time for 
Ca2+ and IP3 (IP3 has a higher diffusion coefficient than Ca2+), the close apposition of the 
two cell types and presence of heterocellular gap junctions allows a rapid diffusion of 
Ca2+ and IP3 from SMC to EC. The unique geometry also favors rapid endothelium 
mediated signaling to the overlaying SMC. Stimulation by an agonist can increase 
calcium and IP1 m one cell (EC or SMC) which can diffuse to the other cell type through 
gap junctions/ ion channels. This way of signaling is termed as chemical intercellular 
communication. Also the K+ ions can diffuse to the intercellular space causing the 
hyperpolarization of one cell. This cell (EC or SMC) can hyperpolarize the other cell by 
electrical coupling through gap junctions/ ion channels. Thus stimulation of one cell can 
effect the functioning of the other cell. This coupling of the two cell types is very 
important as the stimulation of one cell type causes an effect on the other cell type 
thereby regulating the vessel diameter. Fig 4 shows the coupling of the EC and SMC cell 
types as in the vascular walL 
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EC 
Figure 4: Integrated SMC and EC cell 
3.3 ENDOTHELIUM-DERIVED MEDIATORS 
Endothelial cells sense changes (hemodynamic. agonists) m the 
microenvironment of the vessels and transmit signals to the nearby SM cells to regulate 
vascular tone. The Endothelium controls the vascular tone by the release of nitric oxide 
(NO) (48, 67, 107), prostanoids (107) and endothelium derived hyperpolarizing factor 
(EDHF) ( 19, 20, 24 ). These three vasoactive factors are collectively termed as 
endothelium derived relaxmg factors (EDRF). The'le EDRF's diffuse to the adjacent 
smooth muscle layer causing the microvessel to relax. 
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3.3.1 Nitric Oxide 
Murre! established nitroglycerine as a treatment for angina in 1897. lt took the 
scientific community more than 100 years to identify NO as the smooth muscle relaxing 
factor in nitroglycerine. In 1980, Furchgott showed that an intact vascular endothelium is 
a requirement for acetylcholine (Ach) induced relaxation in isolated rat aorta ( 48 ). This 
study provided evidence supporting NO as an EDRF (47). The works of Ignarro, 
Moncanda and Furchgott further supported the role of nitric oxide as an EDRF (47, 48, 
66). In 1988, Moncanda discovered that NO is synthesized in the endothelium from L-
Arginine, a reaction catalyzed by NOS. Bredt and Snyder successfully cloned the enzyme 
nNOS in 1991. 
In the last two decades, the study of NO has received considerable interest 
among the scientific community. NO was declared as the molecule of the year in 1992 by 
magazine "The Science". Another m~or stimulus to the NO research was in 1998 when 
the Nobel Prize was shared among Robert F. Furchgott, Louis J. Ignarro and Ferid Murad 
for work on understanding the physiological role of NO in the vasculature. 
NO role in physiology and pathology 
NO plays a pivotal role in numerous physiological processes such as 
angiogenesis, reproduction, inflammation, neurotransmission, platelet and leukocyte 
adhesion, host defense response, apoptosis, regulation of vascular tone, blood flow etc (2, 
47, 66) . It is also involved in various pathophysiological processes like septic shock, 
atherosclerosis, ischemia/reperfusion injury and carcinogenesis (2, 47, 66). The high 
reactivity of this molecule, which is due to an unshared pair of electron, is responsible for 
the complex role of NO in all the physiological and pathological processes. 
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NO production and action mechanism 
NO is produced in vivo as a free radical by the action of the enzyme nitric oxide 
synthase (NOS). Three different isoforms of NOS exist which are either expressed 
constitutively or their expression is induced by cytokines ( 109, 113). Inducible NOS 
(iNOS) produces NO in the nano to micromolar range. Endothelial NOS (eNOS) and 
neuronal NOS (nNOS) are constitutively expressed and produce NO in the pico to 
nanomolar range. Endothelial cells (EC) use eNOS to produce NO and maintain vascular 
homeostasis (49). nNOS produces NO during neurotransmission in central and peripheral 
neuronal cells. 
In the endothelium, NO is produced by the oxidation reaction of guanidino 
nitrogen of L-Arginine to L-citrulline in the presence of eNOS which is a NOS isoform 
present in the EC. NO is produced by the EC in response to agonist and hemodynamic 
stimulation. NO produced in the EC diffuses to the overlaying smooth muscle cells and 
increases the cyclic guanine monophosphate (cGMP) concentration by a two step 
reaction kinetics (141). NO diffuses from the EC to SMC across cell membranes and 
reacts with soluble guanylate cyclase (sGC) to form a 5 cordinate sGC-NO complex. The 
catalytically active 5 coordinate sGC-NO converts guanine triphosphate (GTP) into 
cGMP. The increase in cGMP in the SMC results in an increase in protein kinase G 
(PKG), which decreases the intracellular concentration of free Ca2+. A decrease in free 
intracellular Ca2+ has an mhibitory effect upon activation of myosin light chain kinase 
(MLCK) and hence results in relaxation of SMC. Relaxation of SMC results in an 
increase in vessel diameter and hence in increased blood flow ( 141 ). 
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activation of sGC though a wide range (23-250 nM) of NO concentration needed for sGC 
activation has been reported (6, 25, 127, 141). The in-vitro deactivation life ofsGC is 10-
lOO minutes in the absence of NO scavengers like myoglobin (87) but the in-vivo 
deactivation life of sGC is less than 2 minutes (107). This allows the SMC to return to 
pre-NO release contracted state after termination of NO production. 
3.3.2 Prostacyclin 
Prostacvclin (PGJ.,) was first discovered in 1976 and was characterized as an 
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endogenous anticoagulator for platelets as well as a strong vasodilator (13 ). This novel 
lipid mediator generated by vascular tissues was the most abundant product of 
arachidonic acid in vascular tissues and was later named as prostacyclin. Like many other 
lipid mediators of the eicosanoid family derived from arachidonic acid, PGI2 is produced 
by the cyclooxygenase (COX) system. Cyclooxygenase is an integral membrane protein 
found in microsomal membranes. It was first purified in 1976, cloned by three separate 
groups in 1988 and is known as cyclooxygenase-1 or COX-I. (74, 75, 132) However in 
1991, several other laboratories identified the product of the second gene with 
cyclooxygenase and peroxidase activities, which was named cyclooxygenase-2 or PGH-
synthase-2 (COX-2) (40, 93). 
Prostacyclin production and action mechanism 
PGI2 is produced by the COX system, Arachidonic acid is converted to 
prostaglandin H2 (PGH2) by COX which is further converted to PGb by the action of 
PGh synthase (PGIS) (133 ), PGh is produced in the body by either COX-! or COX-2 
coupled to PGIS (126). Although, PGh i-; a primary product of COX-2 in certain systems 
(11, 14, 91), the situation vanes depending on the cell types (82). PGb exerts its 
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vasodilator effect in various vascular beds by hyperpolarizing the SMC through one of 
the K+ channels present in the SMC plasma membrane. The signaLing pathway of PGI2 
incorporates a G protein-coupled cell surface receptor termed as IP ( 17 ). Activation of IP 
stimulates adenylyl cyclase leading to an increased production of intracellular cAMP 
which in turn activates protein kinase A cascade, or calcium mobilization via 
phospholipase C activation (17, 18). Both endothelial and smooth muscle cells have the 
capacity to generate PGI2 via PGIS which acts upon vascular tissues and platelets as a 
potent vasodilator. However, in rat mesenteric arterioles, PGh is unable to exert a 
hyperpolarizing effect and hence it is unexpected to exert any vasodilation. However, to 
confirm the role of PGh-mediated relaxation in rat mesenteric vessels, COX-I inhibitor 
(Indomethacin) is used in this study. 
3.3.3 Endothelium Derived Hyperpolarizing Factor 
Earlier pharmacological studies using various inhibitors of metabolism of 
arachidonic acid suggested that atleast three different pathways were involved in causing 
vasodilation. However, at that time only prostacyclin pathway was clearly identified (95). 
De Mey (29) first proposed the existence of a third pathway as the endothelium-
dependent relaxations to acetylcholine obtained in the presence of indomethacin (COX-I 
blocker) were abolished by mepacrine (inhibitor of phospholipase A2) whereas the 
responses to thrombin and ATP were unaffected. Later, Rubanyi ( 119) and Rubanyi and 
Vanhouette (120) showed that under different conditions, the biphasic endothelium 
dependent relaxation to acetylcholine exhihited different susceptibility to antioxidants or 
to inhibitors of the arachidonic acid cascades, thereby providing an evidence for the 
involvement of different relaxing factors. 
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In the late 1970s, Kuriyama and Suzuki observed that acetylcholine produced a 
contraction and a simultaneous hyperpolarization in rabbit and pig coronary and 
mesenteric arteries (76). Later, Nikitina determined that acetylcholine was able to 
produce an endothelium dependent relaxation along with smooth muscle 
hyperpolarization ( 101 ). Thus, it was concluded that endothelium dependent relaxations 
and hyperpolarizations were more or less resistant to inhibitors of cyclooxygenase and 
NO synthase. (8, 26, 58, 118) suggesting an additional pathway that involved the 
hyperpolarization of the smooth muscle which was attributed as EDHF. 
Role in Physiology and Pathology 
The physiological role of EDHF seems to be more prominent in smaller arteries 
and arterioles than in larger arteries. This observation has been made in a number of 
vascular beds, including those from the mesenteric, cerebral and stomach ( 125, 129, 131, 
140). Because of the fundamental role of these smaller vessels in the control of vascular 
resistance, EDHF seems to play a significant role in the regulation of vascular resistance 
and thus in the control of blood flow during normal physiologic conditions. 
Another physiologic role for EDHF may be in conducted dilations of arterioles. 
When an artery or arteriole is stimulated to dilate at a particular site, the dilation can be 
transferred several millimeters upstream and downstream from the foci. This 
phenomenon is termed conducted vasomotor response ( 124 ). This conducted dilation is 
involved in efficient regulation of blood flow within a microvascular network. For 
example, optimum blood flow control in the exercising muscle requires an overall 
coordination of vascular resistances. There can be a risk of insufficient delivery of 
oxygen during times of maximum exercise in the absence of a functional conducted 
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dilator response. The conducted dilation is an important aspect of this coordinated 
response and is required to maximize blood llow control. Local stimulation of endothelial 
cells with Ach evokes conducted vasodilation. ( 124). This phenomenon is endothelium 
dependent which cannot be completely attributed to NO as in some blood vessels NO 
inhibits conducted vasodilations ( 108) . This supports the role of EDHF in conducted 
vasodilations. 
EDHF is also found to play a role in initiation and maintenance of vasomotion. 
Vasomotion is the rhythmic change in arterial or venous diameter which is likely to 
contribute to the harmonious and efficient distribution of blood 11ow. EDHF may also 
help prevent spasm and compensate for disappearance of NO-mediated relaxations under 
hypoxic conditions. (58) 
After many pathologic conditions. dilation produced by endothelium derived NO 
can be significantly reduced. The reduced dilation can be due to a number of factors like 
excessive production of reactive oxygen species, which inactivate nitric oxide, and/or 
dysfunction in eNOS generation of nitric oxide. (22) In contrast, EDHF is resistant to 
reactive oxygen species. EDHF has been reported to be upregulated after a variety of 
pathologic conditions when nitric oxide-mediated dilations have been attenuated. The up-
regulation seems to occur after ischemia--reperfusion, traumatic injury, congestive heart 
failure, coronary artery disease, hypercholesterolemia, and angioplasty. 
The effect of the pathologic condition on the EDHF response can be due to many 
factors. In some pathologic conditions, EDHF production can he down-regulated, 
whereas in other cases it can be up-regulated. (44) In addition, the effect of the pathologic 
condition on the EDHF dilation could be related to the vessel size, the vascular bed, or 
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the severity and duration of the pathologic condition. In those pathologic conditions 
where EDHF is upregulated, it is considered as a protective mechanism that compensates 
for insufficient endothelium-derived nitric oxide. A number of studies suggest that there 
is a balance in the nitric oxide and EDHF response. (61, 73, 96) When the nitric oxide-
mediated dilation is impaired during pathologic conditions, EDHF is up-regulated 
sufficiently to maintain normal dilation. Thus, the relative contributions of nitric oxide 
and EDHF to the overall dilation are adjusted accordingly for the response to remain 
relatively unchanged. 
EDHF Action Mechanism 
EDHF-mediated responses involve an increase in the intracellular calcium 
concentration causing the opening of calcium-activated potassium channels (SKca and 
IKca only in case of rat mesenteric arterioles) present in the endothelial cells leading to 
their hyperpolarization. This results in an endothelium-dependent hyperpolarization of 
the smooth muscle cells, which can be propagated by direct electrical coupling through 
myo-endothelial gap junctions/ion channels and/or the accumulation of potassium ions in 
the intercellular space. Potassium ions hyperpolarize the smooth muscle cells by 
activating inward rectifying potassium channels and/or Na+/K+-ATPase. EDHF causes 
smooth muscle to hyperpolarize by 15-30 m V (88, 140). The smooth muscle 
hyperpolarization causes relaxation by decreasing the concentration of cytoplasmic free 
Ca2+ by closing the voltage-operated Ca2+ channels m the smooth muscle cell membrane. 
The cytoplasmic concentration of free Ca2+ is a major determinant of the contractile state 
of smooth muscle. In addition to regulating Ca2+ concentrations, the sensitivity to 
cytoplasmic Ca2+ can be regulated by kinases and phosphatases to alter the contractile 
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state of vascular smooth muscle. However, it Js not known whether EDHF affects 
vascular smooth muscle sensitivity to Ca2+. 
EDHF-Types 
The acronym EDHF can be misleading as it implies that a single diffusible 
substance mediates this type of endothelium dependent relaxation. Jn fact, there can be 
many endothelium-derived factors including NO and prostacyclin, which can 
hyperpolarize the smooth muscle thus acting as an EDHF. Hence, the endothelium 
mediator which produces hyperpolarization and relaxation should be named adequately 
rather than being denominated as EDHF. The various endothelium-derived factors which 
may play a role of EDHF are as follows: 
Prostacyclin 
Prostacyclin is the major metabolite of arachidonic acid produced by 
cyclooxygenase in endothelial cells. It activates lP receptors on vascular smooth muscle 
thereby causing relaxation in many vascular beds. It can cause hyperpolarization 
depending on the artery and the species by opening one or more types of potassium 
channels. Thus, ATP-sensitive potassium channels (K-ATP), large conductance calcium-
activated potassium channels (BKca), inwardly rectifying potassium channels (Km) 
and/or voltage activated potassium channels (Kv) can play a role in causing prostacyclin-
induced relaxation. Hence, in many cases the prostanoid can be regarded as an EDHF. As 
most of the available inhibitors of cyclooxygenase abolish the production of 
prostaglandins in vascular tissues, any endothelium dependent hyperpolarization 
observed in the presence of one of these inhibitors (Indomethacin) will be independent of 
prostacyclin. 
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NO 
NO also can hyperpolarize vascular smooth muscle cells by activating. potassium 
channels such as K-ATP, BKca, K1R, and/or Kv. NO interacts with other ionic channels of 
the smooth muscle, including chloride and cationic channels as well. NO also influences 
the membrane potential of the smooth muscle cells indirectly in an autocrine fashion. 
However, similar to prostacyclin, the effect of NO as an EDHF can be considered 
abolished in the presence of NOS blockers like L-Name. 
Potassium ions 
Hyperpolarization of the endothelial cells can help achieve hyperpolarization and 
relaxation of the underlying vascular smooth muscle cells through potassium ions. The 
activation of endotheliallKca and/or SKca causes an eftlux or potassium ions from inside 
the cell. This efflux of potassium in the abluminal direction can lead to its accumulation 
in the small intercellular space between endothelial and smooth muscle cells. The 
concentration of K+ ions diffused to the intercellular space can be sufficient to activate 
KtR and/or the Na+/K+ pump on the SMC. Therefore, potassium ions could contribute to 
EDHF-mediated responses. ( 1 00) 
Metabolites of Arachidonic Acid 
Products of cytochrome P450 monooxygenase 
Epoxyeicosatrienoic acids (EETs), derived from cytochrome P450 2C or 2J 
epoxygenases as well as their epoxide hydrolase metabolites dihydroxyeicosatrienoic 
acids, have been reported to induce vasodilation in many blood vessels (42, 43, 114). 
EETs cause arterial SMC hyperpolarization in coronary arteries thereby enhancing the 
open-state probability of BKca channels. EETs can also activate SMC vanilloid transient 
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receptor potential channel (TRPV 4 ), which facilitates in increasing the frequency of 
calcium sparks and transient outward currents. This EET-dependent activation of a 
calcium-signaling complex (TRPV4-ryanodine receptors-BKca) causes SMC 
hyperpolarization and relaxation. (36) 
EETs can play a role in regulating endothelial calcium homeostasis through their 
action on store-operated Ca2+ channels in response to calcium store depletion ( 139) The 
endothelial [Ca2+]i controls the activation of endothelial K+ channels (lKca and SKca in rat 
mesenteric arterioles). EETs may also regulate the activity of endothelial Kca 
independently (7). 
Products of Lipooxygenases 
Endothelial cells can express different lipoxygenases depending on conditions 
(physiological and/or pathophysiological). These lipoxygenases can metabolize 
arachidonic acid into relaxing and contracting substances. Thus, 12-(S)-HETE is released 
from the endothelium by various stimulating factors and functions by activating BKca on 
the smooth muscle cells (39) leading to SMC hyperpolarization and relaxation. 
Hydrogen Peroxide (HzOz) 
Both endothelial and smooth muscle cells generate significant amounts of reactive 
oxygen species. Superoxide is reduced to H20 2 by superoxide dismutase, and can have 
dilator or constrictor properties and hence can either hyperpolarize or depolarize smooth 
muscle. (38) However, evidence supporting role of H20:: as an EDHF and its action 
mechanism is very limited. For example, the type (i.e. IKca. SKca or BKca) and location 
(i.e. endothelial or the smooth muscle cells) of potassium channels that are activated by 
H 20 2 is not yet known. Also, it is unclear whether H20 2 diffuses to activate potassium 
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channels on the smooth muscle or it acts as an intracellular messenger to activate 
endothelial potassium channels. Likewise, although H20 2 is produced in response to an 
increase in endothelial [Ca2+L ( 139) it is uncertain whether this pathway is linked to 
activation of endothelial IKca and SKca or an independent phenomenon. Moreover, H20 2 
docs not relax or hyperpolarize all vascular smooth muscle cells and hence more research 
needs to be carried out to substantiate its role as an EDHF by using specific K+ channel 
blockers and studying H20 2 induced hyperpolarization and relaxation. 
C-Type Natriuretic Peptide 
C-type natriuretic peptide (CNP) causes relaxation and hyperpolarization of 
arterial and venous smooth muscle cells by opening BKca and hence is proposed to act as 
an EDHF (134 ). Experiments in rat arteries suggest that acetylcholine releases CNP from 
EC activating NPR-C receptors on vascular smooth muscle. Hyperpolarization of the 
smooth muscle cell is obtained by the cyclic-GMP-independent activation of a G-protein 
regulated inward-rectifier potassium channel (GIRK). However, more experimentation is 
required to validate its role as an EDHF. For example, the role of CNP-dependent 
activation of NPR-C in vascular smooth muscle cells in producing a cyclic GMP-
independent, pertussis toxin-sensitive signaling is unknown. The expression and activity 
of GIRK has been well-characterized in neurons and cardiac myocytes, but the protein 
expression and characterization of this channel in vascular smooth muscle cells is still 
unclear. Finally it is not known whether CNP can activate GIRK in any cell type. 
3.3.4 Mediators responsible for EDHF induced dilation in rat mesenteric arteriole 
Thus from the above discussion of six different EDHF mediators we can conclude 
that role of NO and prostacyclin as an EDHF is abolished in presence of NOS and COX 
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blocker. Thus, in this study NO and prostacyclin does not exert an EDHF effect. The K+ 
ions can exert an EDHF effect only in presence of IKca and SKcJ present in the rat 
endothelium as stated earlier and hence in the presence of apamin ( SKca blocker) and 
TRAM-34 ( IKcJ blocker), the K+ ions cannot cause EDHF mediated dilation. EETs and 
products of lipooxygenases can exert EDHF effect through either BKCa channels which 
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are not present m rat mesentenc artenolcs or through other K channels present in EC 
which are blocked in this study. Thus, the contribution of metabolites of arachidonic 
acids mediated dilation in this study is expected to be completely eliminated. 
Role of H202 as an EDHF has not been observed in rat mesenteric m1erioles. 
Although it is believed to exert an effect through potassium channels, its action 
mechanism is still unclear. Thus, in this study it is not expected to exert any effect in the 
presence of SKca and IKca blockers. As CNP induces SMC hyperpolarization through G-
protein regulated inward-rectifier potassium channel (GIRK) present on SMC, this 
pathway is not expected to exert any effect as previous studies eliminate the presence of 
Km on rat mesenteric arterioles SMC membrane. Thus, when the endothelial cells of rat 
mesenteric arteriole are stimulated with Ach, there is an increase in EC calcium which 
leads to opening of IKca and SKca channels. As the potassium concentration is higher 
within the cell, therefore potassium diffuses out of the EC into the inter cellular space 
resulting in EC hyperpolarization. This hyperpolarization is transferred to the SMC either 
directly through gap junctions or through the acceleration of Na+/K+ ATPasc pump (by 
additional intercellular K+ ions). 
The N a+ /K+ A TPase pump removes 3 N a+ and intrudes 2 K+ ions. Thus, each 
cycle of this pump is responsible for the removal of one positive charge from the SMC. 
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Hence, acceleration of this pump leads to SMC hyperpolarization as more positive charge 
diffuses out of the SMC. SMC hyperpolarization leads to the closure of L-Typc voltage 
gated Ca2+ channels. This leads to a decrease in SMC intracellular concentration causing 
dilation. Thus, we can conclude that in rat mesenteric arterioles, presence of specific 
blockers of IKca and SKca, are expected to be abolish all the EDHF mediated dilations. 
This is shown in Fig 5. 
4.0 STUDY OBJECTIVES 
This study attempts to elucidate the role of high levels of adrenal cortical hormone, 
ouabain on vascular reactivity. Previous studies on vascular reactivity in the presence of 
ouabain arc very limited and have been performed in bigger diameter vessels like rat 
thoracic rings, human arteries etc (30, 137). Blood pressure is primarily regulated in the 
microvasculature and hence reactivity studies on microvcssels provide a better tool to 
study the role of various agcmists in blood f1ow regulation and regional blood supply. 
Also, as gap junctions between the SMC and EC are important in intercellular 
communication, studies on cultured cells may provide limited information for the 
complex interactions. Also, some of the studies have been performed at very high 
concentrations of ouabain ( -~tM) which is many folds higher than physiological and even 
pathological level. This might be to study the enhanced effect of ouabain as at lower 
ouabain concentraions, experimental determination of ouabain induced difference in 
vascular reactivity might be difficult. 
An in-vitro system of carefully isolated microvcssels should preserve the gap 
junctions/ion channels in the two cell types and facilitate studying the simultaneous effect 
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of agonists on both endothelium and smooth muscle lavers. Microarteries (from male-
sprague dawley rats) in the diameter range of 250-400 microns (pressurized at 50 mmHg) 
were chosen for this study, as microarteries in this diameter range are primarily resistance 
arteries with little or no compliance and provide significant resistance to blood t1ow (27). 
The in-vitro system established for this study is also independent of neuronal and 
hormonal control. The concentration of ouabain used in this study is 1 OOnM which is 
more close to physiological levels than many other studies. The effect of ouabain on rat 
mesenteric microvessel has not been published and hence this study will provide data 
from rat mesenteric arterioles. 
Objective#l: This study aims to measure the effect of NE on arteriolar diameter in the 
presence and absence of ouabain. NE increases SMC Ca2+ through IP3 pathway. Ouabain 
blocks the Na+/K+ ATPase pump leading to further increase in SMC Ca2+ by reversing 
the operational mode of Na+/Ca2+ exchanger. 
Objective #2: This study attempts to investigate the effect of Ach on arteriolar diameter 
in the presence and absence of ouabain. Ach is a known vasodilator and acts by 
stimulating endothelial release of NO, cycloxegenase-derived products and EDHF 
factors. 
Objective #3: This study will investigate the relative contribution of endothelium-
derived mediators in Ach-induced relaxation in the presence and absence of ouabain.Ach-
induced relaxation will be studied by blocking individual pathways. 
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Figure 5: A detailed figure showing the effect of EDHF action mechanism through SKca 
and IKca channels in rat mesenteric artery. 
CHOICE OF ANIMAL AND TISSUE 
Male Sprague Dawley rats weighing 250-300 g and 2-3 month old were chosen as 
the animal subject in order to facilitate comparison of the results of this study with 
available literature. Sprague Dawley rats are easily avmlable and can be housed at the 
animal care facility at Florida International University (FlU). The study is performed on 
intact rat mesenteric arteries as these are high resistance arteries with small diameters 
(250-400 microns) and hence they play a significant role in blood flow regulation. The 
mesenteric artery is easily accessible and well studied. 
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5.0 EQUIPMENT AND INSTRUMENTATION 
5.1 PERFUSION CHAMBER 
The perfusion chamber used in this study was obtained from Living Systems 
1nstmmentation, VT, USA (Model CH 1/SH).The chamber allows to mount intact 
microvessel with the help of glass cannulas. The vessel chamber allows three 
dimensional movements of cannulas. The transparent round glass coverslip ( 150-200 
microns) allows bright field measurements of the microvesscl. The prefabricated chamber 
has a self-heating thermistor controlled by a temperature controller (Model TC-0 l, Living 
Systems Instrumentations,VT, USA), which helps maintain a constant bath temperature 
(37°C) during experimentation. The chamber has a bath volume of 5ml which is suitable 
to cover the microvessel. The inlet and outlet port of the vessel chamber allows replacing 
the superfusate solution and regulating superfusate level in the bath. 
The chamber was connected with silicon tubings (Cole Parmer, IL) and 
used borosilicate glass cannulas (Model GC-12, Living Systems Instrumentation, VT) 
with an internal tip diameter of l 00-200 microns. The smooth beveled tip cannulas allow 
easy cannulation of the microvessel resulting in minimal damage to the endotheium. 
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Figure.6: Perfusion chamber (Living Systems Instrumentation, Model CH/SH 1) 
Pressure transducers (Model PT/F, Living Systems Instrumentation, VT) were 
used in line with perfusion systems tBioscience Tools, CA USA) to monitor perfusion 
pressure on both ends of the vessel. The pressure transducers were connected to pressure 
servo controller (Model PM/4, Living Systems Instrumentation, VT (pressure range: 0-
200 mmHg)) to facilitate regulation of perfusion pressure and perfusate flow. Fast and 
accurate measurement of perfusion pressure is critical for the operation of servo control 
mechanisms as well as for vessel viability. 
Temperature control 
The self heated vessel chamber is fitted with a thermistor sensor (tip dia-1.2mm, 
Living systems Instrumentations, VT, USA) which helps maintaining and measuring 
temperature of the bath solution. The thermistor sensor allows real time measurement of 
bath temperature by sending the temperature signal to the temperature controller (Model 
TC-0 l, Living Systems lnstrumentation, VT, USA). The temperature controller can 
maintain bath temperature within a set range 3"C) during the course of experiment. 
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The bath temperature is set to physiological temperature i.e. 37oc which 1s important to 
obtain vessel response to different stimuli as well as maintain vessel viability during the 
course of experimentation. 
Pressure Servo Controller 
The pressure servo controller is used along with the peristaltic pump to regulate 
pressure and flow through the perfusion lines and the vessel. The servo controller can be 
used in either automatic or manual mode. The two different modes facilitate to test for 
leaks in the vessel. Also, the intra-luminal pressure is regulated with the servo controller 
working in automatic mode. The peristaltic pump can operate in pressure as well as flow 
mode. It can regulate pressure in the range 0-200 mmHg and flow in the range 3 ~L/min-
2.5 ml/min. The pump is used in the pressure mode along with servo controller to 
regulate the intra-luminal pressure of the vessel. 
Flow Pump 
A peristaltic pump (Model FC (Living Systems Instrumentation, VT, USA) was 
used to superfuse different solutions in the vessel chamber. The flow rate of the pump 
was set to 5mllmin so as to replace the bath volume in 1 minute. An alternate method also 
used for superfusing solutions was by adding solutions directly to the bath using a 
syringe. Another pump (Model 77120-62, Masterflex,USA) was connected with the 
outlet port of the vessel chamber to remove the superfusate simultaneously. This is 
required for rapid exchange of bath solution as well as maintaining constant bath level to 
avoid spilling of the solution on the objectives of the microscope. The tlow rates of both 
the pumps were kept the same so that the bath volume remains constant during 
experimentation. However, the studies were done under no flow condition and hence the 
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pumps were used to replace the bath solutions only. This was done to study only the 
effect of agonists on vascular reactivity. Hence, performing the studies in the absence of 
flow provide a better tool to eliminate the effect of flow on vessel responses. 
5.2 MICROSCOPY 
Nikon dissection microscope (Model SMZ645) was employed for microdissection 
i.e. removal of fat from the mesenteric microvessel and identifying artery from vein. The 
same microscope was also employed for adjusting the two cannulas at the same level, 
cannulating the microarteries and suturing the microarteries to the glass cannulas. 
Olympus fluorescent microscope (Motorized Inverted Research Microscope IX-81, USA) 
was used in bright field mode. The microscope components critical for bright field 
experiments were: 
Olympus shutter, Olympus lamp and Camera 
Olympus shutter was used to control exposure time of the light from Olympus 
lamp (IX-2 UCB) onto the vessel. The exposure time was set so that the vessel can be 
seen clearly on the screen and hence the diameter measurements can be performed using 
the lPLab 3.6.3 software. 
The Olympus lamp (IX-2 UCB) was used to provide visible light to the vessel. 
The intensity of the light was controlled manually from the microscope or from the 
software IPLab 3.6.3. 
Cooled mono 12 bit Rctiga Q imaging camera (Model EXi) is employed for 
image acquisition. The camera was operated at a gain of 1557 and an offset of 2048. The 
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gain and offset for the camera were maintained to acquire consistent and comparable 
results 
Objective 
Objective with magnification of 4X was used to record images for this study. The 
objectives have to be focused to get a clear picture of the vessel. The focusing is done 
manually using the microscope. The various specifications of the used objective are 
Magnification Numerical Aperture Working distance (mm) 
4X 0.16 8.2 
Table 1: Important objective ( 4X) characteristics 
IPLab 3.6.3 for windows 
Depth of field 
55.5 
Software IPLab3.6.3 Windows verston (Scanalytics, VA, USA) was used to 
control the microscope and the associated hardware. IPLab3.6.3 allows control of shutter, 
filter wheel, camera and objectives. The diameter measurements were recorded with the 
help of the software manually as well as with the script for measuring diameter in bright 
field mode. 
6.0 METHODS AND PROCEDURES 
6.1 CONTROL SOLUTION 
Hyclone cell culture grade water (Hyclone, Utah, USA) was used in preparing 
control solution for the study. The control solution was prepared to make the solution 
physiological in terms of osmolarity and pH. This is necessary for to obtain vessel 
response as the cells can die if placed in non-physiological solution. The composition of 
the control solution is given in the table below. 
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Salt Concentration (mM) 
NaCl 118.7 
KC! 5 
CaCl2 2.5 
MgS04 1.2 
KH2PO_. 1.2 
HEPES 20 
Glucose 5 
Table 2: Composition of the control solution 
The various salts and concentrations used to prepare the solution were obtained 
from protocols used by other studies. The control solution was filtered before 
experimentation to remove any impurity from the salts and avoid contamination during 
experiments. The prepared solution was checked for osmolarity and pH before each 
experiment to ensure the solution had a physiological osmolarity range (280-300m0sm) 
and pH range (7 .4±0.05). This is important for keeping the cells functional and obtaining 
response from the vessel. The pH was adjusted using 1M NaOH solution. The osmolarity 
was measured using the osmometer (Advanced Instruments. USA) and pH using the pH 
meter (Fischer Scientific, USA). 
VASOACTIVE AGENTS 
All the chemicals and drugs were obtained from sigma chemicals, USA except for 
KB-R7943 which was purchased from Calbiochem, USA. Fresh solutions were prepared 
before every experiment and serial dilutions were made to obtain the required 
concentrations. 
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NE as a vasoconstrictor 
Norepinephrine (NE) was used as an agonist for vasoconstriction m a 
concentration range of O.l ~tM to 1 OrtM. NE was superfuscd in the bath of the vessel 
chamber to act on the smooth muscle cells of the microartery. The NE increases the 
intracellular Ca2+ in the SMC though IP3 pathway thereby leading to vessel constriction. 
The NE was stored in powdered form at -20°C in a scaled container. The starting solution 
of lOmM NE was prepared before every experiment. The solution was then serially 
diluted to obtain working NE solutions of concentration 0.1 ~M, 0.2~M, 0.4~tM, 1 [tM, 
3~M and lO~M. These concentrations were used as they provide a broad range of 
constrictions in the vessels starting from low constriction (at O.lftM) to maximum 
constriction (at around lO~M). More number of points provides a better curve and more 
accurate EC50 values. The working solutions were then tested for osmolarity and pH and 
were determined to be in working range of 280-300 mOsm and pH of 7.4±0.05. NE was 
superfused with the help of a peristaltic pump at a flow rate of 5mllmin to ensure a 
complete bath solution ( -5 ml) turnover in 1 min. The outlet pump was connected at the 
outlet port of the vessel chamber to ensure a constant level of bath solution. 
Acetylcholine as a vasorelaxant 
Acetylcholine was applied as an agonist to produce vasorelaxation from a 
concentration range of lnM to lO~M. Ach stimulates endothelial cells to produce various 
signaling factors like NO, prostacyclin and EDHF. This endothelial generated signaling is 
transferred to the underlying SMC thereby causing relaxation. A I OmM stock solution of 
Ach was prepared before each experiment. The solution was then serially diluted to 
obtain working Ach concentrations of lnM, !OnM. 30nl'v1, lOOnM, l~tM, lO~tM and 
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IOO~M. These concentrations were used as they provide a broad range of relaxations in 
the vessels starting from lower relaxation (at l nM) to maximum relaxation (at around 
lOO~tM). More number of points provides a better curve and more accurate EC50 values. 
The working solutions were checked for osmolarity (280-300) and pH (7.4+0.05). The 
working solutions were continually perfused at 37oC through the microartery at 
approximately 50 )lL/min using a 20 mmHg pressure difference across the perfusion 
chamber as a driving force. The flow rate and pressure difference used here generates a 
wall shear stress at the vessel wall which lies in the range of physiological pressure (1-10 
dynes/cm2) and hence maintains the integrity of the endothelium. Higher pressure 
gradient can result in higher flow rate, which can damage the endothelial monolayer. 
Short flow lines ensured a small dead volume and hence rapid switching between agonist 
and control solution through the microvessel. Extreme care was applied to ensure 
complete removal of bubbles in the perfusion line as presence of bubbles can also 
damage the endothelium. 
6.2 BLOCKERS USED 
Indomethacin 
Indomethcain solution (I O~M) was perf used through the microvessel to block 
COX-1 which is responsible for the production of prostacyclin by the endothelium. 
Indomethcain was perfused for 25-30 mins followed by a 5-l 0 min washout period. This 
ensured complete blockade of COX-1. All the Ach solutions were then perfused and 
diameter responses to different Ach concentrations were obtained to study the 
contribution of prostacyclin in causing relaxation. 
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L-Name 
L-name solution (350!-tM) was perfused through the microvcssel to block the 
effect of NO in causing vessel relaxation. L-Narne blocks eNOS, thereby inhibiting the 
endothelium from producing NO. L-Name was perfused for 25-30 minutes followed by a 
wash out period of 5-l 0 mins. This ensured complete eNOS blockade. All the working 
solutions of Ach were again perfused and diameter-concentration dose response curves 
were obtained to study the contribution of NO in causing vasorelaxation. 
Apamin 
Apamin solution (1 O~tM) was used to specifically block SKca channels in the 
endothelium of the microvessel. The solution was perfused through the artery for 25-30 
minutes followed by a 5-10 min washout period. This was used in conjunction with IKca 
channel blocker (Tram-34) to completely block the EDHF effect. The K+ channels cause 
endothelium-dependent smooth muscle hyperpolarization leading to closure of VGCC 
thereby causing smooth muscle relaxation. Hence, their blockade should be able to 
abolish EDHF-mediated relaxation. The IKca blocker used is described below. 
Tram-34 
Tram-34 solution (0.1 !lM) was used to block IKca channels in the endothelium of 
the microvessel. As, the EDHF effect in rat mesenteric arterioles is mediated by calcium-
activated potassium channels present in the EC layer (i.e. SKca and IKca in this case), 
therefore both Apamin and Tram-34 were used to eliminate the EDHF effect in 
vasorelaxation. Perfusion and washing times used for Tram-34 are similar as for Apamin. 
Different Ach solutions were then perfused after perfusing both apamin and Tram-34 to 
obtain diameter- response curves. 
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Ouabain 
Ouabain solution (200nM) was prepared and mixed in equal amounts with various 
NE concentrations to have lOOnM ouabain concentration in all the NE solutions. Ouabain 
was used to block the Na +;K+ ATPase pump in the vascular SM. Different concentrations 
of NE having 1 OOnM ouabain were then perfused to obtain dose response curves. Effect 
of ouabain on Ach-induced relaxation was measured by perfusing Ach solutions (lnM-
100[1M) to vessels preconstricted with 0.5~tM NE and lOOnM ouabain. 
KB-R7943 
KB-R7943 (2-(2-(4-(4-Nitrobenzyloxy) phenyl) ethyl) isothiourea, methane 
sulfonate) was stored as a stock solution in DMSO. 4 flM of KB-R7943 solution was 
prepared and mixed with equal amounts of NE solutions to have 2flM of KB-R7943 in 
all the NE solutions. KB-R7943 was used to block the Na+/Ca2+ exchanger operating in 
n:verse mode. The effect of KB-R7943 on NE response in presence of ouabain \Vas 
studied by adding it to the superfusate containing 0.5f1M NE and l~tM Ouabain. 
RAT EUTHANASIA MICRODISSECTION AND CANNULATION 
All procedures and protocols used in this study were approved by the institutional 
animal care and use committee (IACUC) at the Florida International University (approval 
# A3096-01). Male Sprague Dawley rats (2-3 month old weighing 200-250 g) were 
obtained from Harlan (Indiana, USA) and housed at FlU animal care facility. Rats were 
euthanized with 100% C02 in a gas chamber. 
Rat dissection was performed under '>terile conditions and the mesenteric arcade 
was excised and immediately transferred to the control solution at 5°C. Immediate 
transfer of the mesenteric arcade to the control solution at 5°C reduces damage to the 
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mesentery. An intact mesenteric arcade was selected and was fixed to a sylgard coated 
dissection dish using pins (Fig.7). Care was taken to always submerge the mesenteric 
arcade under cold control solution by continually replacing the control solution in the 
dissection dish with fresh control solution at 5°C. 
Figure 7: Rat mesenteric arcade spread in control solution at 5°C. 
The mesenteric arcade is placed on a sylgard coated dissection dish and fixed 
usmg pms. Microsurgery was performed under dissection microscope to physically 
remove the fat surrounding the microartery. Care was taken to ensure selection of 
approximately 0.5 mm long arteriolar segment without branches or leaks. The 
microartery was successfully distinguished from a microvein based upon the vessel wall 
thickness and vessel compliance and isolated. Physical removal of fat and vessel isolation 
was preferred over chemical dtgestion of fat. Physical vessel isolation technique is 
tedious and requires longer period of time but has been determined to be the method of 
least damage to the microvessel (35). The final cutting of the vessel from the mesentery is 
extremely critical to experimental success and was performed under fresh cold control 
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solution to prevent the microvessel from spasm. The isolated vessel was immediately 
transferred to the microvessel cannulation chamber containing control solution at 5°C. 
Microsutures were obtained from Living Systems Instrumentation, VT, fashioned in to 
knots and loaded on to the cannulas beforehand. Care was taken to keep the suture length 
short to prevent them from accidentally touching the microartery during the experiment. 
Cannulas and perfusion tubing were flushed with control solution at the start of the 
experiment to prevent air pockets and air bubbles within the perfusion line. Removal of 
bubbles is imperative for a successful experiment as air pockets can disrupt the 
endothelial monolayer of the microartery. The system was continually tested for presence 
of air pockets by observing the response time of the system to a change in servo pressure 
controller set point. A delayed servo response to a change in set point indicated the 
presence of air bubble in the lines. 
Microvessel was allowed to stabilize to the new environment for 5 minutes. It was 
lifted from one end and slipped over the glass cannula connected to the servo control-
peristaltic pump combination. The cannulated end was secured with the help of two 
microsuturcs tied gently around the microvessel (Fig.8). Care was taken to maintain the 
physiological direction of flow through the microartery. The microartery was always 
lifted from the ends to prevent any damage to the SMC at the region of interest due to 
handling. The cannulated end was gradually pressurized up to 5 mmHg to remove the 
blood inside the vessel lumen. 
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Figure 8: Bright field image of a cannulated rat me~entery microartery secured with the 
help of two microsutures (imaged using Olympus 4X objective). The diameter of the 
vessel pressurized to 50mmHg is v~300~tms) 
Care was taken to mamtain extremely low flow rate of control solution through 
the vessel to avoid erosion of the endothelial monolayer. After removal of intraluminal 
blood, microvessel perfusion was stopped and the second end was cannulated and 
secured using two microsutures. Four microsutures arc sufficient to withstand a pressure 
of up to 150 mmHg in the vessel. The microvessel was pressurized to 80mm Hg and then 
the bend formed was removed by adjusting the cannulas. This is done to pre stretch the 
microvessel so that it responds maximally to various agonists. The pressure was then 
reduced to physiological pressure of 50 mmHg and the vessel was tested for leaks by 
switching the servo controller from automatic to manual mode and observing any 
changes in the intraluminal pressure. A significant drop in intraluminal pressure indicates 
a leak. Only vesseb without leaks were considered for experimentation. 
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6.3 EXPERIMENTAL SET UP FOR APPLICATION OF AGONISTS TO 
SMOOTH MUSCLE AND ENDOTHELIUM 
The experimental set-up for superfusing vasoactive agents like NE, Ouabain and 
KB-R7943 and perfusing agonists and/or blockers like Ach. Indomethacin, L-Name, 
Apamin and Tram-34 is shown in Fig.9. The set-up established IS ideal for experiments 
involving continuous superfusion and can be adapted depending upon the individual 
experimental protocol. The present set-up is sufficient for the proposed experiments 
involving application of NE, Ouabain and KB-R7943 to the microarteries by superfusion 
and application of Ach, Indomethacin, L-Name, Apamin and Tram-34 to the endothelium 
by perfusion. 
6.4 BRIGHT FIELD IMAGING, DIAMETER MEASUREMENTS, 
RECORDING MOVIES FOR VASOMOTION 
Imaging criterion was fixed to ease comparison of data. The microartery was 
imaged with IPLab3.6.3 software using light from Olympus lamp. The exposure time was 
set to obtain a clear picture of the vessel. IPLab3.6.3 ratio plus extension was used to 
acquire images, which were stored for future analysis and post processing. The vessel 
response to various stimuli was recorded by either taking snapshots or by making a movie 
with time frames of 5 sec. All the vasomotion movies were recorded using a time frame 
of I sec only to measure amplitude and frequency of oscillations. 
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Figure 9: Experimental set-up for application of agonists' through continuous superfusion 
and perfusion. 
6.5 POST PROCESSING 
Images were also post processed using IPLab3.6.3 to obtain diameter changes at 
different cross-sections. Diameter measurements were made manually as well as using 
the script in the software for measuring diameters in bright -field mode. The diameter 
data was exported to Microsoft Excel for the characterization of the response. The 
diameter responses were normalized and plotted against the concentration of agonists in a 
logarithmic scale. EC50 values were then determined using Hill plot equation as described 
later. 
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6.6 STATISTICS 
Dose response curves were analyzed statistically by using two way analysis of 
variance (ANOV A) test for multiple comparisons. Constrictions /relaxations were 
compared at individual agonist concentrations and the points which were determined to 
be statistically different were shown with a symbol. The two-way ANOV A was used to 
compare the difference between individual blockers and the Post-Hoc test (Tukey test) 
was used to determine the significance values for each of the point. 
SUMMARY OF EXPERIMENTATION 
reparation of Solutions, agonists, blockers 
Preparation of Chamber 
Rat Euthanasia, Removal of Mesentery 
icro-dissection to isolate microartery 
annulation and Pressure test for any leaks 
Application of agonists 
Imaging and Post processing 
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\Vithout Ouabain (Control experiments) 
Dose response curves with NE only (6 rats) l 
l 
Dose response curves for Ach without any 
blocker (n=6) 
_l 
Dose response curves for Ach with 
blockers (Indomethacin (n=3), L-Name 
(n=5), Apamin+ Tram-34 (n=4)) 
\Vith Ouabain 
Dose response curves with NE (n=4) 
1 
Dose response curves with Ach without 
any blocker as well as with L-Name and 
Apamin+ Tram-34 (n=4) 
7.0 RESULTS 
7.1 Pressure vs Diameter 
Increase in intra-luminal pressure causes an increase in microvessel diameter. As 
shown in Fig 10 a & b, an increase in pressure leads to a decrease in the slope of the 
pressure vs diameter curve and at 80mm Hg pressure the slope tends to reach a plateau. 
Normalized data from 5 separate rat experiments is shown in Fig. 1 Oa whereas average 
normalized diameter increase is represented in Fig. 1 Ob. On increasing the intra-luminal 
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pressure to 80mmHg, the microvessel diameter increased by 44.5(±1.5) Cl() and the slope 
of the curve approaches a plateau. 
Figure 10: Diameter response to increase in mtra-luminal pressure from Oto 80mmHg m 
isolated intact rat mesenteric arteriole. Vessel diameter tends to plateau as the pressure 
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reaches 80mm Hg exhibiting myogenic response. Diameter increase is normalized over 
basal diameter at OmmHg. 
In (a) raw data (n=5) is shown whereas in (b) data is shown as percentage mean 
relaxation± SEM; n=5. 
7.2 Control studies of vascular reactivity 
7.2.1 Effect of vasoconstrictor NEon vessel diameter 
Vasoconstriction was obtained upon application of NE showing an intact and 
functional SM layer. NE concentration in the bath chamber was progressively increased 
to O.l!JM, 0.2~tM, 0.4!JM, l!JM, 3!JM and lO~tM. As the NE concentration was 
increased, a higher constriction was observed in the microvessels. A concentration-
response curve was obtained showing microvessel constriction resulting from different 
NE concentrations. Fig. lla shows raw data obtained from 6 rat experiments whereas 
Fig. ll b shows the mean percentage relaxation (±SEM ). Constriction was calculated 
based on the basal diameter of the vessel without NE in the bath solution. The normalized 
percentage constriction at any NE concentration Ci was calculated using the formula: 
%Constriction (at Ci) = (Do-Di)/Do ............................................................ (l) 
Where, Di is the vessel diameter at NE concentration Ci and Do is the basal diameter of 
the vessel without NE in the bath solution. 
A maximum constriction ±SEM of 46.5 (±2.5(/c) was obtained at 3~tM NE as 
shown in Fig. 11 b. The EC~o i.e. the concentration of NE to obtain 50% of the maximum 
'- ' 
constriction was calculated from the dose-response curve using the l1ill equation . As the 
constriction response curve followed a sigmoidal shape. a Hill equation was used to 
describe the curve: 
C n/ (C n ·Ec n) (2) Ri=Rmax i i + 50 · · · · · • · · · · · · · · · · · · · • · · · · • · · · · · · · · · · · · · · · · • · · • · · · • · · · • · · · · · · · · · · · • · · • · · · · · 
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Where, Ri is the constriction at concentration C of NE and Rmax 1s the maximum 
constriction. 
The values of hill coefficient (n) and EC:;o were calculated by plotting log10 [Rmax I 
(Ct+ECsct)] vs log10 [Ci] and fitting a line through the curve. The slope of the line 
provided the value of n whereas the value of EC;o was calculated with the help of the 
both intercept and slope [EC50=Intercept/n). To further optimize the value of EC'io 
obtained from above method, the constriction values corresponding to various 
concentrations of NE were calculated from the Hill equation (eqn 2) using the values of 
Ci, Rmax, n and EC50. The constriction values obtained experimentally and from the Hill 
equation were subtracted, squared and the sum of square of errors was calculated. Now, 
the value of square of sum of error was minimized by changing EC50 and hill coefficient 
(n). The EC50 values were obtained for individual experiments to obtain the result as 
average ±SEM and were found to be 0.46(±_0.15) ~tM. 
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(b) 
Figure 11: Concentration-response curve for NE induced constnct1on in isolated rat 
mesenteric rat arterioles. Increase in NE concentration (0.1!-!M-10!-!M) caused an increase 
in vessel constriction leading to maximum constriction of 46.5±2.5 o/o and EC50 of 0.46 
± 0.15 ~tM. Constriction is normalized over basal diameter i.e. the diameter at 50mmHg 
without NE in the chamber bath. 
In (a) raw data is shown; (n=6) whereas in (b) data is expressed as percentage mean 
constriction± SEM; (n=6). 
Vasomotion was observed almost every time after NE application showing intact 
and functional ion channels/gap junctions thereby proving good handling of the vessel. 
Vasomotion, which is characterized by a rapid oscillation of vessel diameter, occurs on 
application of vasoconstrictors like NE and KCJ and is reported as a random event ( 121 ). 
A diameter oscillation is shown in Fig 12 as a function of time from a single experiment. 
Vasomotion was observed in the NE concentration range 0.4!-!M-1 ~tM with an average 
time period of 4 (±1.5) seconds. 
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Figure 12: Application of NE in the concentration range 0.4~tM-I~M often resulted in 
vasomotion. The diameter oscillations observed have an average oscillation period of 4 
(±1.5) seconds. 
7 .2.2 Acetylcholine-induced Relaxation 
Yasorelaxation was obtained on application of acetylcholine to the arterial 
endothelium showing an intact and functional endothelium. The microarteries were 
pressurized to 50 mmHg and preconstricted with 1 ~tM NE. The concentrations of Ach 
used werelnM, lOnM, 30nM, lOOnM, l~tM, lO~tM and lOO~tM. 
Ach induced a dose-dependent relaxation of the NE preconstricted microvessel as 
shown in Fig 13. Raw data from 6 different rat experiments is shown in Fig. 13a, \vhereas 
an average relaxation-concentration curve is shown in Fig. 13b. All the relaxations were 
normalized using the formula: 
Relaxation (at Ci) = (Di-Do)I(Dt-Do) . .,. 0 .................................................. (3) 
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Where, Di is the diameter of the vessel obtained after perfusing concentration C of Ach, 
Do is the diameter of vessel after prcconstriction with NE and Dt is the initial diameter of 
the vessel before preconstriction. 
Ach was able to completely reverse the NE induced constriction, thereby relaxing 
the vessel to its original diameter. The EC50 value i.e. the concentration of Ach required 
to relax the vessel to 50% of its maximum relaxation was obtained following the same 
method as used for NE-induced constriction (Hill equation) and was found to be 50 (±24) 
nM. The maximum relaxation obtained was 95(±4.5) %. 
(a) 
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(b) 
Figure 13: Concentration response curve for Ach-induced relaxation in isolated intact rat 
mesenteric arterioles preconstrictcd with 1 !-!M NE. Ach was able to almost completely 
reverse NE induced constriction giving a maximum relaxation of 95(±4.5) and EC50 
of 50±24nM. 
In (a) raw data is shown; (n=6) whereas in (b) data is expressed as percentage mean 
relaxation ±_SEM; (n=6). 
7 .2.3 Effect of Indomethacin on Ach induced relaxation. 
Indomethacin solution ( lO!-!M) was perfused for 30 minutes to block COX-! 
following the same procedure as for Ach. COX-1 is responsible for the production of 
prostacyclin in the endothelium of rat mesenteric artery and hence its inhibition blocks 
the prostacyclin pathway of Ach-induced relaxation. Indomethacin was perfused for 30 
minutes followed by a l0-15 min wash out period. Different Ach concentrations (1 nM to 
lOO~lM) were again perfused to obtain a concentration response curve of Ach-induccd 
relaxation in the presence of COX inhibitor. 
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The COX blocker had no significant effect on Ach induced relaxation as the Ach was 
able to almost completely reverse the NE induced constriction even in the presence of 
indomethacin (Fig 14). The maximum relaxation obtained was 90.5(±1.5) and the ECso 
value obtained in the presence of indomethacin was 75 (±17) nM. Although the 
maximum relaxation was slightly impaired, the difference was not statistically significant 
which was confirmed by two-way ANOV A test for multiple comparisons (p<O.O 1 ). 
61 
Figure 14: Concentration response curve for Ach-induced relaxation in isolated intact rat 
mesenteric arterioles preconstricted with l !J-M NE in the presence of COX blocker 
indomethacin. Ach evoked relaxation was not significantly affected in the presence of 
indomethacin. The maximum relaxation observed in presence of indomethacin was 
90.5(±1.5) (;.(;whereas EC_,0 in this case was 75±l7nM. 
In (a) raw data is shown; (n=3) \Vhereas in (b) data is expressed as percentage mean 
relaxation± SEM; (n=3). 
7.2.4 Effect of eNOS blockade on Ach-induced relaxation 
Endothelial nitric oxide synthase blocker (L-Name, 350~tM) was used to block the 
NO production in the arterial endothelium. L-Name solution was perfused for 30minutes 
followed by a 10-15 minute washout period. All the concentrations of Ach were again 
perfused to obtain the concentration -response curves as shown in Fig15. NOS blockade 
had a significant effect on the Ach-induced relaxation. The maximum relaxation was 
impaired in comparison to control conditions thereby showing a major role of NO in 
Ach-induced relaxation. The maximum relaxation obtained in the presence of L-Narne 
was 54.5(±3.5) whereas the EC50 value for this curve was found to be 45 (±32) nM. 
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(b) 
Figure 15: Concentration response curve for Ach-induced relaxation in isolated intact rat 
mesenteric arterioles preconstricted with I !AM NE in the presence of e-NOS blocker, L-
Name. Ach evoked relaxation was significantly affected in the presence of L-Name. The 
maximum relaxation observed in presence of L-Name was 54.5(±3.5)% whereas EC50 in 
this case was not affected significantly (45 ±32 nM). 
In (a) raw data is shown; (n=5) whereas in (b) data is expressed as percentage mean 
relaxation± SEM; (n=5). 
7.2.5 Effect of blocking EDHF pathway in Ach-induced relaxation 
Selective potassium channel blockers were used to block the EDHF pathway m Ach 
induced vasodilation. As discussed earlier, in rat mesenteric arteries, EDHF exerts its 
effect through potassium channels present in EC ( rat mesenteric arterial EC contains 
only IKca and SKca) and hence specific blockers for IKca (Tram-34,0.1 ~AM) and SKca 
(Apamin, I 0~-AM) were perfused for 30 minutes each followed by a washout for I 0-15 
minutes. Since, the same vessel has been perfused with Indomethacin and L-Name, the 
perfusion of Apamin and Tram-34 results in the blockage of all the three pathways. All 
the Ach solutions were again perfused to obtain the concentration-response to Ach 
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induced vasodilation. The potassium channel blockers almost completely abolished the 
Ach-induced relaxation as shown in Fig 16. The maximum relaxation obtained was 13.5 
(±3.5). Fig. l6c shows the effect of blocking all the patlw,·ays on Ach-induced relaxation. 
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Figure 16: Concentration-response curve for Ach-induced relaxation in isolated intact rat 
mesenteric arterioles preconstricted with 1 ~tM NE after blocking all the three pathways. 
In (a) raw data is shown; (n=4) giving concentration response to Ach-induced dilation in 
the presence of blockers Indomethacin, L-Name, apamin and Tram-. Blockade of all the 
three pathways almost abolished the Ach-induced dilation. In (b) the data is expressed as 
percentage mean relaxation± SEM; (n=4). In (c) the contribution of all the pathways is 
shown. (p<O.Ol) (*)different from control and(**) different from Indo+L-name. 
7.3 Effect of Ouabain on Vascular Reactivity 
Ouabain (used to block the Na+/K+ ATPase pump) was superfuscd along with NE 
to study its affect on NE induced vasoconstriction. The effect of ouabain on NE-induced 
constriction and vasomotion was recorded. Ach-induced relaxation was also examined to 
study the effect of ouabain on vascular reactivity. Different blockers (L-Name, Apamin 
and Tram-34) were also applied in the presence of ouabain and their effect on Ach-
induced relaxation was recorded and compared with control experiments. 
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7.3.1 Effect of Ouabain on NE induced constrktion-response curve 
Addition of 1 ~tM ouabain to NE preconstricted vessel caused a significant constriction 
(47.4 ~m) as shown in Fig. 17a. However, the effect of IOOnM ouabain on the steady-
state diameter of the microvessel was not significant. Ouabain ( IOOnM) was superfused 
along with different NE concentrations (0.1 ~M to 1 O~M) to determine the effect of 
ouabain on NE induced concentration-response curve in rat mesenteric arterioles. The NE 
induced vasomotion did not abolish in the presence of ouabain as shown in Fig. 17b and 
the resulting time period of oscillation was 4.7±1.5s. Fig. 17c shows raw data obtained 
from 4 rats (n=4) illustrating the concentration response of NE in the presence of 
ouabain. Fig. 17d illustrates the data as percentage mean constriction ± SEM whereas 
Fig. 17e shows comparison of NE induced vasoconstriction in presence and absence of 
ouabain. The maximum constriction obtained in presence of ouabain increased to 50(±2) 
% compared to a maximum constriction of 46.5(±2.5) (11: obtained in the absence of 
ouabain. The EC50 obtained in presence of ouabain was 0.53 (±0.1 0) ~-tM compared to 
0.46(±0.15) ~M (which was obtained in the absence of ouabain). 
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Figure 17: Effect of ouabain on NE induced vasoconstriction in isolated rat mesenteric 
artery. 
In (a) diameter response on adding I ~M ouabain (in the presence of 0.5~M NE) is 
shown. (b) shows the effect of ouabain on NE induced vasomotion. In (c) raw data; (n=4) 
showing the NE induced concentration-dose response in the presence of I OOnM ouabain 
is illustrated and (d) demonstrates the data as percentage mean constriction± SEM (n=4 ). 
In (e) comparison of NE induced concentration- response in the presence and absence of 
ouabain is shown. Although, the NE induced constriction was slightly increased in the 
presence of ouabain, there was no statistical difference. 
Effect of NCX Blockade on NE induced vasoconstriction 
Blockade of Na+/Ca2+ exchanger with 2~tM KB-R7943 (added to the superfusion, in the 
continuous presence of NE and ouabain) resulted in a biphasic response. At first, the 
addition of KB-R 7943 caused an initial constriction as shown in Fig. 18a. This was 
followed by a relaxation after a certain time lapse. The time lapse between the 
constriction and relaxation was approximately I OOseconds. Concerning vasomotion, the 
oscillation period increased to 8 seconds as shown in Fig. l8b. 
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Figure 18: Effect of NCX blockade with 2[1M KB-R7943 on NE induced constriction in 
the presence of ouabain. 
In (a) transient response from a single experiment is shown. The vessel constricts initially 
after addition of 2~1M KBr and l ~tM ouabain in the presence of 0.5[1M NE followed by a 
relaxation. In (b) the effect of KB-R7943 on NE induced vasomotion is shown. The time 
period of diameter oscillation increases to 8seconds. 
7.3.2 Ach-induced dilation in the presence of Ouabain 
All the concentrations of Ach solutions (lnM to IOO~tM) were perfused through 
the isolated intact rat mesenteric arteries preconstricted with 0.5~tM NE and lOOnM 
ouabain. The effect of Na+/K+ ATPase blocker on Ach mediated dilations was studied in 
vessels presconstricted to approximately 50% of its initial diameter. Raw data from 4 rats 
is shown in Fig. l9a whereas data as percentage mean relaxation ± SEM is shown in Fig. 
19b. Presence of ouabain significantly impaired Ach induced vasodilation to 29.5(±2.2) 
compared to 95± relaxation {in ouabain absence). Fig. 19c shows a comparison 
of the Ach-induced dilation in the presence and absence of ouabain. The values of 
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relaxations which were statistically different are shown on the curve. The EC50 obatined 
with ouabain was I 0(±3) nM which was statistically reduced compared to the EC50 in 
ouabain absence (50±24nM). 
(b) 
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Figure 19: Ach induced relaxation response in isolated intact rat mesenteric arterioles 
preconstricted with 0.5uM NE and I OOnM ouabain. 
In (a) raw data is shown; (n=4) whereas in (b) the data is expressed as percentage mean 
relaxation± SEM; (n=4). (c) shows a comparison of Ach-induced dilation in the presence 
and absence of ouabain. *(p<O.OI) and #(p<0.05). 
Effect of L-Name on Ach-induced dilation in presence of Ouabain 
The effect of eNOS blockade on Ach induced relaxation response in the presence 
of ouabain was studied in rat mesenteric vessels. eNOS blockade did not significantly 
effect Ach induced relaxation in the presence of ouabain. The maximum relaxation 
obtained in this case was 30.5(±2.5) o/c: and the EC50 reduced to 82 (±3) nM. Fig. 20a 
shows raw data from four rat experiments showing Ach induced relaxation response in 
the presence of L-Name whereas in Fig. 20b the data is expressed as percentage mean 
relaxation ± SEM. Fig. 20c shows the comparison of Ach induced relaxation response 
with and without eNOS blockade in the presence of ouabain. 
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Figure 20: Effect of NOS blockade on Ach-induceci relaxation response in the presence 
of IOOnM Ouabain. 
In (a) raw is shown (n=4) whereas in (b) the data is expressed as percentage mean 
relaxation± SEM (n=4). (c) shows the comparison of Ach relaxation response with and 
without NOS blockade in the presence of ouabain. The eNOS blockade (in the presence 
of ouabain) did not affect the Ach induced dilation significantly. 
7.3.3 Effect of EDHF blockade on Ach induced relaxation in presence of Ouabain 
The blockade of NO as well as EDHF pathways was again performed as done 
before for control studies and the Ach induced relaxation response was studied in 
presence of Na+ /Kt ATPase blocker, Ouabain. Similar protocol was followed to block the 
SKca and IKca channels in the rat mesenteric arteriolar endothelium as used earlier for 
control studies. The SKca and IKca channels were blocked in the presence of L-Name. 
Since prostacyclin was not found to play a significant role in Ach induced dilation, 
indomethacin was not used in this case. Raw data from four rat experiments is shown in 
Fig. 21 a whereas data is expressed as percentage mean relaxation ± SEM in Fig. 21 b. 
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Blockade of EDHF pathway nearly abolished the Ach induced vasodilation. The 
maximum relaxation obtained in this case was 9(±3.5) %. Fig. 21 c shows the comparison 
of blockade of all the pathways on Ach-induccd dilation in the presence of ouabain. 
A<;h Coflcentration (M) 
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Figure 21: Effect of eNOS and EDHF blockade on Ach-induced relaxation in isolated 
intact rat mesenteric arterioles preconstrictcd with 0.5uM NE and lOOnM ouabain. 
In (a) raw data is shown (n=4) whereas in (b) data is expressed as percentage mean 
relaxation ±SEM (n=4). (c) shows a comparison of blocking all the relaxation pathways 
on Ach-induced relaxation in the presence of ouabain. Points that are significantly 
different from control are denoted with* (p<O.Ol). 
8.0 DISCUSSION 
Pressure vs. Diameter 
The percentage increase in resting diameter of the vessels was plotted as a 
function of intra-luminal pressure. In this study, we found that on increasing the intra-
luminal pressure to 80mmHg, the microvessel relaxed by 44.5( + 1.5) % as well as the 
slope of the curve almost reached a plateau at 80mmHg. This finding is consistent with 
other studies who have reported the diameter increases as a function of intra-luminal 
pressure in isolated cannulated rat mesenteric arteries (5, 111). 
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NE induced Vasoconstriction 
NE increases the SMC Ca2+ through IP3 pathway thereby causing constriction. In 
this study, NE induced a dose dependent constriction in rat mesenteric arterioles showing 
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an intact and functional SM layer. Few studies have previously reported NE induced 
constriction response curves (5, 111, 112). This study reports a maximum constriction of 
46.5(±1.5 %) and ECso of 0.46±0.15f.!M which is in close agreement with previous 
studies of Poureguard et al who reported a maximum constriction of 40(±5%) and an 
ECso of0.72(±0.1) ~tM (112). Also the maximum constriction was observed at 3~AM NE 
which is in close agreement with Poureguard's study. However, some studies have 
reported a higher maximum constriction of up to 80% as well as a higher ECso of the 
order of 3.35f.!M (85). 
Schuster et al (121) has reported that in-vitro observation of vasomotion is highly 
dependent on the proper handling of the vessel. The occurrence of vasomotion is highly 
dependent on the integrity and functionality of ion channels and gap junctions present in 
SMC which can be easily disrupted during the dissection and cannulation of the vessels. 
In this study, we observed vasomotion almost every time thus ensuring good vessel 
handling. In this study, vasomotion was observed at NE concentration range of 0.4~tM to 
1 f.!M which is in agreement with Schuster's findings. The time period of diameter 
oscillations observed in this study was 4.0 (±1.5) seconds which is in close agreement 
with a time period of 5.0(± 1.1) seconds as observed by Schuster et al ( 121 ). 
Ach induced relaxation •·esponses 
Ach induces vasorelaxation by stJmu1ating endothelial mediated release of NO, 
prostacyciin and EDHF. Various studies have been performed to study the relative 
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contribution of NO, prostacyclin and EDHF in vasodilation of rat mesenteric arterioles. 
Dose-dependent diameter response curves to different Ach concentrations have been 
widely published in literature as Ach causes relaxation involving all the three pathways. 
In most of the studies, various groups preconstricted the mesenteric arterioles to 
approximately 50% of maximum constriction using NE or a similar vasoconstrictor 
thereafter perfusing different Ach solutions with concentrations ranging from lnM to 
lOO!lM. 
However, to study the contribution of individual pathway, different blockers have 
been used to block individual pathways. NO synthase blocker L-Name has been widely 
used to inhibit the production of NO in the endothelium, Indomethacin is used as a COX-
1 blocker to inhibit prostacyclin induced dilation and Kca channel blockers are used to 
inhibit the EDHF effect. In rat mesenteric arterioles, the endothelium is found to contain 
IKca and SKca only. Thus specific blockers for SKca (Apamin) and IKca (Tram-34, 39) 
have been used to prevent vasodilation due to hyperpolarization. Other studies in rat 
mesenteric arterioles have also used a cocktail of apamin and charybdotoxin (blocker of 
IKca and BKca) to abolish EDHF effect. 
From past literature, Ach is able to completely reverse the NE induced 
constriction in almost all the studies performed on rat vessels (16, 17, 23, 32, 34, 37, 46, 
62, 64, 77, 78, 105, 106, 125, 129). These studies report a maximum relaxation in the 
range (85-100) % and EC50 values in the range (30-155 )nM This study reports a 
complete relaxation of NE induced constnction, thus supporting all the previous 
published data. The EC50 value for Ach induced relaxation was found to be 50±24nM 
which is in close agreement with the EC50 values published before. However, some 
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variation in EC50 values is expected due to different levels of preconstrictions used in 
various studies. 
Contribution of prostacyclin in Ach induced vasodilation was studied by blocking 
COX-I using indomethacin (IO[.!M). Previous experimental studies on rat mesenteric 
arteries show that prostacyclin does not have a significant contribution in Ach induced 
dilation (16, 17, 23, 32, 34, 37, 46, 62, 64, 77, 78, 105, 106, 125, 129). These studies 
have obtained maximum relaxation in the presence of Indomethacin in the range (90-100) 
% and an EC5o in the range quite similar to control conditions ( 49-185) nM. The results 
of this study are consistent with these findings as the maximum relaxation produced in 
the presence of indomethacin was found to be 90.5(±1.5) whereas EC50 value was also 
not significantly affected (75±17nM). However, very few studies (83) have reported a 
significant effect of indomethacin in rat mesenteric arterioles (maximum relaxation 
60.5±4.5) 
However, blocking NO synthase using L-Name (350~tM) has shown to have a 
significant effect on Ach induced relaxation thereby providing evidence of a significant 
role endothelial-derived NO in causing vasodilation in rat mesenteric arteries. Previous 
experimental studies on rat microvessels have reported a significant decrease in Ach 
induced dilation in the presence of L-Name (16, 17, 23, 32, 34, 37, 46, 62, 64, 77, 78, 
105, 106, 125, 129). These studies have reported a maximum relaxation after eNOS 
blockade in the range (48-82) and an EC\0 value between (65-300) nM. In this study, 
presence of L-Name reduced the Ach-induced maximum relaxation to 54.5(±3.5) 
whereas the EC50 value was also not significantly affected (45±32nM). 
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EDHF-mediated responses involve an increase in the intracellular EC calcium 
concentration causing the opening of calcium-activated potassium channels (SKca and 
IKca only in case of rat mesenteric arterioles) present in the endothelial cells leading to 
their hyperpolarization. This results in an endothelium-dependent hyperpolarization of 
the smooth muscle cells, causing vessel relaxation by decreasing the concentration of 
cytoplasmic free Ca2+ by closure of voltage-operated Ca2+ channels in the smooth muscle 
cell membrane. Thus, blockade of SKca and IKca should eliminate EDHF-mediated 
relaxation in rat mesenteric arterioles. Various studies have been performed using a 
cocktail of apamin (1 O!lM) along with elther of Tram-34, Tram-39, Charyhdotoxin or 
Iberiotoxin. Perfusing these blockers in the presence of L-Name and Indomethacin has 
been found to almost completely abolish the vasodilation (16, 32, 34, 37, 46, 62, 64, 77, 
78, 105, 106, 125). These studies have reported a maximum relaxation in the range (0-12) 
%. In this study, we found a maximum relaxation of 13.5 (±3.5). Although the relaxation 
was greatly reduced, it wasn't completely abolished. This may be due to incomplete 
blockade of K+ channels or involvement of some other pathway. 
Table 3 shows a comparison of the results of this study with previous reports for Ach-
induced dilation (in the presence of various blockers) in the absence of ouabain. 
% Maximum RclaxatiOJ 
Previous Studies This Study 
Control (85-100)% (95±4.5)% 
Indomethacin (90-100)% (90.5± l.5Yfo 
Indo+L-Name (48-82)% (53.5±3.5)% 
All Blockers (0-12) % ( 13.5+3.5)% 
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EC50 (nM) 
Previous Studies This Study 
Control (30-155) (50±24) 
Indomethacin (49-185) (75±15) 
Indo+L-Name (65-300) (45+22) 
Table 3: A comparison of% maximum relaxation and EC50 values obtained in this study 
with previous reports for Ach-induced dilation in rat vessels (in the absence of ouabain). 
Effect of Ouabain on NE induced Vasoconstriction 
Cardiotonic steroids, including the adrenal cortical hormone ouabain, have been 
proposed to play a role in some forms of hypertension as its production is reported to 
increase in the state of hypertension. Ouabain may affect microcirculatory vascular 
resistance through inhibition of the N a+ /K+ A TPase; leading to an accumulation of N a+ 
inside the cell, reversal of the Na+/Ca2+ exchanger (NCX), and accumulation of Ca2+ in 
the cytosol. In this study, we tested the effect of ouabain on NE induced 
vasoconstriction. There haven't been any studies reporting concentration-response curves 
toNE induced constriction in the presence of ouabain. The concentration of ouabain used 
in this study ( lOOnM) is higher than the physiological/pathological levels in the body 
(1 pm-lOnM). Using lower ouabain concentrations has experimental limitations as its 
effect cannot be seen on vessel diameter responses. Also, using supra-physiological 
concentration provides a good tool to study the effects of ouabain on all the pathways 
involved in regulating vessel diameter. The maximum constriction obtained in presence 
of ouabain increased to 50(±2) % compared to a maximum constriction of 46.5(±2.5) (7a 
obtained in the absence of ouabain. 
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Although, the increase caused due to ouabain is not statistically significant, it is 
important to note that blood pressure is inversely proportional to the fourth power of 
vessel diameter and hence small changes in diameter can significantly affect blood 
pressure. In this study, vasomotion did not abolish in the presence of 1 !tM ouabain which 
is in contradiction with some studies (53), but consistent with others (121 ). The 
abolishment of vasomotion observed by some groups could be due to a difference in the 
tissue studied or partially impaired ves<.,el leading to abolishment of vasomotion. 
Effect of NCX blocker 
The Na+/Ca2+ exchanger was blocked using 2~tM KB-R7943 solution. Addition of 
KB-R7943(2~M) along with ouabain( 1 ~M) toNE prcconstricted vessel gave a hi-phasic 
response, with at first as expected for a blockade of Na+/K+ ATPase pump, caused an 
initial constriction due to ouabain effect (an increase in SMC Na+ leading to reversal in 
direction of NCX thereby causing SMC Ca2+ increase). However, after some time ( !00s) 
the NCX blocker effect becomes predominant leading to a relaxation (As KB-R7943 
blocks the NCX operating in reverse mode, thereby reducing SMC c}+). However again, 
the diameter oscillations were not abolished and resulted in a higher time period as 
reported by Schuster ( 108). 
Effect of Na +;K+ ATPase blockade on Ach-induced vasodilation 
Effect of N<tl K+ ATPase pump blockade on Ach-induced dilation has an 
impmiant significance in understandmg the role of ouabain in hypertension. Very few 
studies have been performed to study this effect and hence very limited data is available 
in the literature. Some studies found an impairment in relaxation to Ach in some vascular 
beds (30, 137) whereas some tissues did not exhibit any difference (18, 128). There is no 
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data on ouabain effect on Ach-induced dose curve in rat mesenteric arteries which is 
provided by this study. Interpretation of experimental findings is complicated by 
inherited limitations in traditional studies of vascular reactivity. Chang et al. (15) point 
out that the vast majority of experimental studies utilize isolated vascular rings of large 
vessels and not vessels from the microcirculation, where blood t1ow and pressure is 
mostly controlled. Large arteries may behave significantly different than resistance 
m1erioles. In this study, presence of 1 OOnM ouabain along with 0.5!1M NE was able to 
significantly impair Ach-induced relaxation (p<O.Ol ). The maximum relaxation was 
obtained as 29.5(±2.5)% compared to 95(±4.5) obtained \Vithout ouabain. 
One of the limitations of this study was the use of high concentration of ouabain. 
The pathological concentration of ouabain is ~ 1 OnM whereas the concentration of 
ouabain used in this study was 1 OOnM. Lower concentrations of ouabain did not induce 
any measurable difference in NE-induced constriction and hence this study utilized a 
higher concentration to study its effect. However, the effect of I OnM ouabain on Ach-
induced relaxation should be studied in future. 
The mechanism of ouabain-induced inhibition of relaxation remains controversial. 
To test the hypothesis that ouabain impairs the NO mediated vasodilation, L-Name was 
perfused to block the NO production followed by application of different Ach 
concentrations. Surprisingly, there was no significant difference in the presence and 
absence of L-Name, thus confirming the significant effect of ouabain on NO pathway in 
Ach-mediated vasodilation in rat mesenteric arterioles. 
The ouabain-induced compromise in NO-mediated relaxation can be due to many 
reasons. Firstly, ouabain may impair the ability of endothelium to produce NO thereby 
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compromising its effect. This can be verified by studying relaxation on perfusing 
exogenous NO solutions or studying the NO production by loading NO-sensitive dye 
DAF-FM to check for NO production in the presence of ouabain. 
A second explanation can be due to SMC Ca2+. NO causes relaxation by opening 
the BKca channels (directly or indirectly) and thereby causing SMC hyperpolarization. 
The resulting hyperpolarization results in the closure of VGCC thereby inhibiting Ca2+ 
entry into SMC. However in the presence of ouabain, Na+/K+ ATPase blockade causes an 
increase in SMC Na+ resulting in a reduced Ca2+ efflux through NCX leading to an 
inversion of NCX thereby causing Ca2+ entry. Thus, in this scenario, although NO 
inhibits Ca2+ entry through VGCC, SMC ci+ continues to increase because of the 
reverse operating mode of NCX thereby inhibiting relaxation. To test this hypothesis, 
more studies need to be performed by applying NCX blocker (KB-R9743) and perfusing 
Ach in presence of ouabain. A restored relaxation on application of KB-R7943 will 
provide strong evidence supporting the above hypothesis. 
Ouabain induced impaired relaxation can also be attributed to a loss of K+ 
gradient in SMC. As the Nc.t/K+ ATPase pump blockade leads to a reduced intracellular 
K+ (along with increased Na+), this reduced K+ can impair the ability of the SMC to 
hyperpolarize. As discussed earlier, NO exerts its effect by hyperpolarizing SMC (i.e.by 
opening BKca channels leading to loss of intracellular K+). Reduced intracellular K+ 
concentration due to ouabain can lead to a reduced SMC hyperpolarization which in turn 
may lead to delayed or partial inhibition of VGCC: (thereby increasing SMC Ca2+). Thus 
NO effect can be compromised again and hence more studies need to be performed by 
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monitoring the SMC membrane potential during Ach perfusion m the presence of 
ouabain. 
The relaxation observed after eNOS blockade shows the contribution of EDHF-mediated 
relaxation. In this study, ouabain was also found to impair EDHF-mediatcd relaxation 
although partially. Since, EDHF produces relaxation by hyperpolarizing SMC, we can 
suggest from the above two findings that ouabain plays a role in compromising SMC 
hyperpolarization. However, more significant loss of NO mediated relaxation may be due 
to combined effect of less SMC hyperpolarization and NO production by the 
endothelium. 
Thus, further studies needs to be carried out to study the action mechanism of ouabain 
which can lead to design preliminary clinical studies to find a treatment of ouabain 
induced hypertension. 
9.0 Conclusion 
This study has been successful in establishing a system for in-vitro experimentation 
on isolated microvessels. The study investigated vascular reactivity by studying the 
effects of vasoconstrictor NE and vasorelaxant Ach in the presence and absence of 
adrenal cortical hormone, ouabain. NE resulted in a dose dependent constriction of the 
microvessel with and without ouabain. However, the maximum constriction was slightly 
but not significantly increased in the presence of ouabain. This suggests that high ouabain 
levels do not increase the sensitivity of microvessels to vasoconstrictors significantly. 
Ach was able to completely reverse the NE induced constriction in the absence of 
ouabain. Prostanoids did not play a significant role in Ach mediated vasodilation whereas 
85 
NO and EDHF contributed almost equally in the absence of ouabain. Ach-induced 
relaxation was significantly impaired in the presence of ouabain. The NO pathway was 
significantly impaired in the presence of ouabain whereas the EDHF pathway was 
partially compromised. Thus during ouabain-induced hypertension, high ouabain levels 
lead to higher blood pressure as the arteriolar diameters are smaller. Ouabain impairs 
relaxation to vasodilators much more significantly than enhance constriction to 
vasoconstrictors. 
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